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Patients in South Africa
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Department of Mathematical Sciences,
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc. (Mathematics)
March 2017
Understanding and quantifying human peripheral blood T-lymphocyte immunophe-
notypes is necessary for the diagnosis and treatment of immune and haematological
disorders. This is only possible if comparison to control-data from healthy subjects is
available for all the biomarkers of interest. Historical empirical studies in industrialized
countries have described normal reference ranges for such biomarkers in children by
grouping particular age ranges into ‘age-blocks’. Since such markers change with age
this has resulted in a loss of precision in determining whether patients that lie close to
the limits of age-ranges are normal or not. Previous studies have relied on fitting single
exponential models to such data, which makes the simple assumption of an exponen-
tial decline in cell markers with age. However, the counts of such markers have been
observed to increase from birth to between 6 months to 12 months from birth and then
decrease continuously with age. There is a dearth of reference range estimation methods
which are age-continuous and incorporate biologically mechanistic models. A more ideal
solution would be the development of appropriate mathematical models and model-
based, age-continuous reference range estimation methods that describe such changes
in a continuous manner. Such models may then be used to investigate the influence of
population covariates on age-related changes in the biomarkers of interest. In this study,
we employ paediatric data from a cohort of 381 healthy South African children. This is
ii
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cross-sectional in design and the biomarkers described include: CD3+, CD19+, CD8+,
CD4+, ratio of CD4+ naive/memory, CD18+CD56+ and CD3-CD56+. Using weighted
generalized nonlinear least squares, we fit and compare single and double exponential
semi-mechanistic models. An ideal model is selected based on the Akaike’s Information
Criterion (AIC). The double exponential model is found to be the best fit for age-related
changes in such biomarkers. This predicts that cell counts rise after birth to a maxi-
mum at approximately 12 months of age and decline in an exponential manner towards
an asymptote in adulthood. This is in agreement with prior empirical and mechanistic
studies. We extend the double exponential model to investigate the influence of par-
ticular covariates. The type of feeding in the first 6 months following birth is found to
be the covariate with the greatest influence on age-related changes in the majority of
the biomarkers investigated. A model-based method to estimate age-continuous refer-
ence ranges is then proposed. This assumes that particular reference ranges are a spec-
ified shift of the ‘running’ standard deviations of residuals away from a fitted central
model function by a Z-score. We compare this method to reference ranges calculated
using traditional centile curves. Centile curves demonstrate a simpler negative single-
exponential decline as age advances and enable no mechanistic interpretation for this
pattern. The models employed in this study may lead to the development of a labo-
ratory tool by which individual cell-marker values may be compared to healthy age-
continuous reference ranges.
Keywords: immunological cell biomarkers, healthy children, model-based, age-continuous
reference ranges.
Stellenbosch University  https://scholar.sun.ac.za
Opsomming
Die skatting van Immuun-Biomerker Verwysings Waardes vir gesonde
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(“Immune Biomarker Reference Range Estimation for Healthy Paediatric Patients in South Africa ”)
Steve Bicko Cygu
Departement Wiskundige Wetenskappe,
Universiteit van Stellenbosch,
Privaatsak X1, Matieland 7602, Suid Afrika.
Tesis: MSc. (Wiskunde)
Maart 2017
Die diagnose en behandeling van immuun en hematologiese afwykings benodig die be-
grip van en kwantifisering van menslike perifere bloed T-limfosiet immuun-fenotipes.
Dit is slegs moontlik indien vergelyking met data van gesonde pasiente beskikbaar is vir
al die biomerkers van belang. Historiese empiriese studies in geïndustrialiseerde lande
het al sulke normale verwysings waardes vir kinders beskryf, maar deur groepering van
die data in spesifieke ‘ouderdoms-blokke’. Aangesien sulke biomerkers aanhoudend
verander met ouderdom, het dit gelei tot ‘n verlies aan akkuraatheid in die bepaling van
normaliteit van pasiënte wat naby aan die grense van sulke ouderdoms-groepe lê. An-
der studies het staatgemaak op die pas van enkel-eksponensiële modelle op sodanige
data, wat die eenvoudige aanname maak van ‘n eksponensiële afname in sel merkers
met ouderdom. Dit was wel al waargeneem dat sulke merkers verhoog vanaf geboorte
tot tussen 6 en 12 maande na geboorte en dan voortdurend daal met vergrotende ou-
derdom. Daar is ‘n gebrek aan verwysings waarde skattings metodes wat ouderdom-
aaneenlopend is en biologies meganistiese modelle inkorporeer. ‘N Meer ideale oplos-
sing sou die ontwikkeling wees van toepaslike wiskundige verwysings waarde skat-
tings metodes wat model-gebaseer en ouderdoms-aaneenlopend is. Sulke modelle kan
dan gebruik word om die invloed van koveranderlikes wat ouderdoms-verwante veran-
iv
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deringe in die biomerkers van belang veroorsaak te ondersoek. In hierdie studie gebruik
ons die ouderdoms-deursnee data van ‘n groep van 381 gesonde Suid-Afrikaanse kin-
ders. Wat die volgende biomerkers insluit: CD3+, CD19+, CD8+, CD4+, die verhouding
van CD4+ naïef/geheue selle, CD18+, CD56+ en CD3-CD56+. Ons gebruik dan nie-
lineêre kleinste kwadrate metodes om enkel en dubbel eksponensiële semi-meganistiese
modelle te pas en vergelyk. Die ideale model is gekies op grond van die Akaike se in-
ligtings Maatstaf. Sodoende bepaal ons dat die dubbel eksponensiële model die mees
geskik is om ouderdoms-verwante veranderinge in sulke biomerkers aan te dui. Hier-
die model voorspel dat seltellings styg na geboorte tot ‘n maksimum by ongeveer 12
maande en daarna eksponensiël daal tot ‘n asimptoot in volwassenheid. Hierdie resul-
taat stem ooreen met vorige empiriese en meganistiese studies. Daarna gebruik ons die
dubbele eksponensiële model om die invloed van koveranderlikes te ondersoek. Die
koveranderlike met die meeste invloed was die tipe voeding in die eerste 6 maande na
geboorte. Model gebaseerde metode wat ouderdoms-aaneenlopende verwysings waar-
des skat is daarna voorgestel. Hierdie metode veronderstel dat die verwysings waar-
des ‘n gespesifiseerde Z-verskuiwing van die ‘lopende’ standaardafwykings van die re-
sidue vanaf die sentraal gepaste model funksie is. Ons vergelyk hierdie metode met
tradisionele persentiel kurwes. Persentiel kurwes toon ‘n eenvoudiger negatiewe enkel-
eksponensiële daling met ouderdom, en is nie in staat om meganistiese interpretasies te
maak vir hierdie patroon nie. Die modelle wat in hierdie studie voorgestel is mag lei
tot die ontwikkeling van ‘n laboratorium instrument waarmee individuele sel-merker
waardes kan vergelyk word met gesonde ouderdoms aaneenlopende verwysings waar-
des.
Sleutelwoorde: immunologiese sel biomerkers, gesonde kinders, model gebaseer, ouderdoms-
aaneenlopende verwysings waardes.
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Chapter 1
Introduction
1.1 Background
Understanding and quantifying human blood lymphocyte immunophenotypes (immune
biomarkers), i.e. cell-surface markers or clusters of differentiation (CD) is necessary for
the diagnosis and treatment of immunological and haematological disorders. This in-
cludes autoimmune and infectious diseases, such as HIV, which may give rise to se-
lective marker proliferation or deficiency. CD4+ antigen provides a primary binding
site for the HIV virus. Acquired Immunodeficiency Syndrome (AIDS) results in the de-
cline in the counts of CD4+ T cells with consequent invasion by opportunistic infections.
CD4+ T cell counts are commonly used to determine when to commence and monitor
HIV patients in highly-active antiretroviral treatment (HAART) programs, assess pro-
gression of immunological diseases and the prophylaxis of opportunistic infections [50].
Since CD4+ T cells are the only routinely monitored markers in HAART, historical stud-
ies of cell-surface markers have mainly focused on only this one. Few studies have sys-
tematically investigated changes in cell-markers from birth through adulthood for the
blood lymphocyte immunophenotypes of any of the other main lymphocyte subgroups
[51]. A proper understanding of the changes in all blood lymphocyte subsets can only
be achieved if comparison to control-data from normal (healthy) subjects is available for
the markers of interest [24].
Homeostatic proliferation in the thymus ensures maintenance and production of cell-
surface markers. In paediatric patients, the immature immune system produces quanti-
tatively different numbers of peripheral blood cell-surface markers compared to adults
[29]. For instance, an adult has approximately 3000 lymphocyte cell/ml in the periph-
1
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eral blood, while in children, the number of cell-surface markers rises from birth to a
maximum (approximately 4000 cell/ml) between six months [50] to one year of age [7],
it then follows an exponential decline as the child grows to adulthood. This is due to a
number of inter-related factors. For example, the progressive involution of the thymus
in the first 20 years of life, exposure to antigens and the alteration of naive to memory cell
ratios associated with immunological ‘learning’. Other factors include the rapid change
in body size and blood volume associated with growth and the progressive age-related
replacement of primary thymic production by peripheral cell division [29]. As a re-
sult, both the Centers for Disease Control and Prevention (CDC) and the World Health
Organization (WHO) have developed age specific CD4+ cell count systems for use in
classifying children into appropriate ‘immune-categories’ [50].
Although considerable progress has been made in immunological research over the
last decade, quantifying lymphocyte dynamics remains a challenge. There are diver-
gent predictions of blood lymphocyte population estimates and age-related changes in
them. These include varying estimates of thymic production, cell division rates and T
cell lymphocyte longevity. As a result, quantification and understanding of homeostatic
processes and the naive lymphocyte repertoire remains challenging [29]. Various experi-
mental methods and techniques have been employed to empirically quantify peripheral
blood cell surface markers. The requisite antibodies and laboratory techniques for flow
cytometric immunophenotyping are generally expensive and time-consuming, and fur-
ther, the use of T-cell receptor excision circle (TRECs) is problematic as these change in
quantity over time [29]. Lymphocyte cell marker measurements are also characterized
by large inter-individual variation with measured residuals which are not usually dis-
tributed in a Gaussian normal pattern (personal experience).
Reference ranges are commonly used in medicine to compare individual clinical mea-
surements to population values. There have been relatively few studies describing nor-
mal reference ranges for all the major cell surface markers [24, 33, 95] and of these,
all were conducted in first-world industrialized countries. The comparability of such
ranges to those for people in resource-limited settings, such as Sub-Saharan Africa (SSA),
is questionable given the different environmental and immunological milieu. Histori-
cal studies in industrialized countries have described normal reference ranges for such
biomarkers in children by grouping particular age ranges into ‘age-blocks’ [24, 95]. Since
such markers change continuously with age this has resulted in a loss of precision in de-
termining whether patients that lie close to the limits of age-ranges are normal or not.
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Other studies have fitted single-exponential models to such data, simply assuming an
exponential decline in cell markers with age [48]. However, the counts of such markers
have been empirically observed to increase from birth to between 6 months to 12 months
and then decrease continuously with age. The current paediatric immunological refer-
ence intervals in use in the South African National Health Laboratory Service (NHLS)
have been adopted from international publications [33, 65, 95].
Although limited paediatric immunohaematological reference ranges have been pub-
lished from Africa [50, 67, 69, 71, 93, 105], the values vary considerably between coun-
tries and regions. The variations in the international and African reference data have
been attributed to, among other factors, ethnicity, diet, endemic infections, altitude and
the testing methodologies used. Other factors may include inadequate number of sam-
ples used in the analysis and the failure to provide confidence intervals around the pre-
dicted central values.
Studies that are longitudinal in design are relatively expensive and are prone to difficul-
ties in following-up the respondents. Cost cutting in the form of cross-sectional study
designs excludes the effects of longitudinal individual aging but does show ‘age snap-
shot’ population behaviour. This in turn necessitates large sample sizes within particu-
lar age ranges which then hopefully represent the biological dynamics within. The large
sample sizes also tend to negate the cost-cutting efforts. In view of the challenges asso-
ciated with empirically determining biomarker reference ranges, a working group, The
Clinical and Laboratory Standards Institute Approved Guideline (3rd edition) for defin-
ing and establishing reference intervals [21].
An alternative to purely empirical methods for determining cell marker reference ranges
lies in fitting non-linear mechanistic or semi-mechanistic models to such data [7, 8, 29, 48,
110]. Such models vary in terms of the number of parameters to be estimated and the
assumptions made regarding the underlying age-related dynamics. In the case of semi-
mechanistic models, they make only the assumption that the change in the cell marker
with increasing age is an exponential which proceeds to an asymptote in adulthood
[48]. However, the simplicity of such an assumption somewhat detaches it from the
underlying biological mechanism. Fully mechanistic models, on the other hand, may
require difficult or even impossible-to-measure parameters in order for them to be fit-
ted to peripheral blood biomarker data [29]. The benefits of models as compared to
purely empirical methods lies in their requiring relatively fewer subjects to enable a fit
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to data along with the ready ability to calculate descriptive statistics, such as the me-
dian and 95% confidence intervals. Further, they represent age as a continuous rather
than an age-range-limited variable [48, 110]. Thus, the data are not split into arbitrary
‘blocks’ but represent the continuous change in the biomarker over time. The applica-
tion of such models does hold challenges. For example, the requisite specification of
the assumptions regarding the underlying biological dynamics, statistical procedures
which require normality assumptions, and the absence of model-based statistical meth-
ods to determine age-continuous reference ranges [48]. The main difference between
mechanistic or semi-mechanistic models and purely empirical methods is that mechanistic or
semi-mechanistic models require an understanding and incorporation of the underlying
biological mechanisms while purely empirical methods simply involves the calculation of
descriptive statistics such as mean, median and standard deviation of the cell markers.
In the current study we review appropriate background immunobiological information.
However, the focus is primarily on a mathematical investigation of age-related changes
in paediatric peripheral blood immune biomarkers (CD positives). We compare single
and double exponential models and extend the double exponential model to investigate
the influence of covariates. We also develop a robust model-based approach to estimate
age-continuous reference ranges. The latter method is compared with commonly used
centile curves.
From a technical perspective it is desirable to have robust diagnostic mathematical tools
and methods by which to compare the quality of the model fits and the calculation of
reference ranges for this type of data. Such methods may lead to the development of
easily employed tools for the laboratory that enable the determination of whether indi-
vidual cell marker values are normal or not, in a precise and age-continuous manner.
The age-continuous, model-based reference estimation algorithm has resulted in devel-
opment an R software package which will be available for public release. The resolution
of these issues provides a methodical foundation by which similar data may be analyzed
in the future, and may also provide insights into the biological questions that remain,
regarding age-related changes in immune biomarkers.
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1.2 Biological background
Lymphocyte cell markers form an important part of the immune system which allows
the body to initiate responses to invading pathogens. T cell lymphocytes express recep-
tors on their surfaces which, together with major histocompatibility (MHC) molecules,
enables them to identify particular antigen-peptides. As part of the adaptive immune
system this offers long-term protection against reinfection by a particular antigen [68].
The development process of the peripheral blood lymphocytes involves the production
of T cell precursors in the bone marrow, development in the thymus and entry into the
circulating pool as mature T cells. Mature T cell lymphocytes are identified by their ex-
pression of CD3+, CD4+, CD8+ or other antigens. This involves extensive cell differenti-
ation, division and selection, as well as T cell receptor (TCR) gene rearrangement. How-
ever, only a small percentage of T cell lymphocytes live through this process to enter the
circulating pool [9]. Lymphocytes are composed of T-lymphocytes, B-lymphocytes and
natural-killer (NK) cells. The development of T-lymphocytes takes place in the thymus
whereas B-lymphocytes develop in the bone marrow in adults and in the foetal liver.
T cell receptors (TCR) determine the binding affinity of T cell clones bound to major
histocompatibility complex (MHC) molecule. In other words, the receptors expressed
by individual T cells on their surfaces help in recognizing specific antigen-peptides in
association with the MHC molecules. T cell clones are very specific to peptides bound
to a single MHC (pMHC) and activates the appropriate T cell clone. During T cell de-
velopment in the thymus, the T cells that are specific for self-pMHC complexes are de-
activated. This ensures that T cells only respond to foreign antigens. T cell clones are
subdivided into naive, activated, effector, and memory cells [9, 68].
1.2.1 T cell development, function and activation
The development of peripheral T lymphocytes takes place in the thymus. The produc-
tion of T cell precursors begins in the bone marrow; lymphocyte development, ’thy-
mopeisis’, occurs in the thymus and these then enter the peripheral circulating pool as
mature T cells [9, 75]. T cell development in the thymus is characterized by cell differ-
entiation, cell division, T cell receptor (TCR) gene rearrangement and cell selection. The
thymus is composed of the following: non-lymphatic tissues, thymic epithelial space
(TES) and lymphocytic perivascular space. Thymic epithelial space is divided into cor-
tex and medulla. Only a small percentage of thymic lymphocytes survive and enter the
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circulating pool [9, 52]. Thymopoiesis takes place mainly in the TES, which contains
approximately 90% of the thymocytes at any particular time [42, 59]. Before cell divi-
sion and maturation, cell proliferation which involves TCR β chain rearrangement takes
place in the cortex. Just before this rearrangement, the CD4 positive and CD8 positive
subpopulations are upregulated by the thymocytes to become double positive, i.e. posi-
tive to both markers. Thereafter, the thymocytes move to the cortex for a vigorous selec-
tion process which leads to the formation of two major subpopulations, namely: CD4+
helper T cells and CD8+ cytotoxic T cells [29]. In this process cells that are not capable of
binding to self-peptides bound to MHC molecules die by neglect (a process which elim-
inates those T cells which would be non-functional due to an inability to bind to MHC),
which accounts for 80% − 90% of thymocytes loss [109]. Single positive thymocytes
move to the medulla through the expression of chemokine receptor, CCR7. After this,
the thymocytes (referred to as mature naive T cells) then enter the peripheral circulating
population [9]. Immature cells that express very high affinity to self-peptides on MHCs
are lost through apoptosis, which refers to a normal, genetically regulated process lead-
ing to the death of cells and triggered by the presence or absence of certain stimuli.
The final stages of thymic development involves sequential changes in the expression of
surface markers and the functional activation of thymocytes for various stimuli [54, 112].
The principal function of T cells is to recognise the foreign antigens presented by antigen
presenting cells (APCs) and to elicit appropriate responses. This process is catalysed by
MHC molecules and takes place in the secondary lymphoid organs. T cell activation
occurs as a result of expansion of T cell receptor clones, followed by activation of naive
T cells which undergo vigorous cell proliferation and cell differentiation to produce ef-
fector and memory T cells. The effector T cells produced at this stage are capable of de-
stroying infected cells and producing cytokines that are able to stimulate B cells. Large
numbers of effector T cells are believed to die through apoptosis, leaving only a small
minority to move to the memory T cell pool [3, 80]. The factors affecting T cell func-
tion and activation include: TCR activation strength, presence of environmental stimuli,
binding extent, MHC peptide exposure and other co-stimulation factors [9].
1.2.1.1 Naive T cell function and activation
At any given time, only 2% of lymphocytes are found in the circulating peripheral blood.
The other 98% of lymphocytes are distributed throughout the other tissues of the body.
However, almost all the lymphocytes pass through the blood every day [10, 98]. Naive
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T cells are exported from the thymus and are in continuous circulation between periph-
eral blood and the secondary lymphoid organs. Secondary lymphoid organs, which
include lymph nodes and the spleen, maintain mature naive lymphocytes and initiate
an adaptive immune response. Naive T cell peptides are presented by the APCs, B lym-
phocytes or dendritic cells (DCs), while still in the secondary lymphoid organs. This
enables them to identify specific antigens through a high speed random process. The
half-life of a naive T cell within a given lymph vessel is approximately a quarter of an
hour. Cells which are not able to recognise their specific antigen return to lymphoid
circulation through different lymph nodes. Chemokine receptors (CCR7, CXCR5 and
CD31, among others) regulate the recirculation of naive T cells into the lymph nodes
[87, 108].
Immune responses and TCR signals in the activated naive T cells are initiated by MHC
peptides binding to the antigen specific TCR/CD3 complex [9]. The activation process
of naive T cells is determined by the level of TCR affinity, co-stimulation and inflam-
mation. Co-stimulation is not only necessary for proliferation and cell survival but is
also important in the production of cytokines and trafficking of synapses to appropriate
antigen recognition. Naive CD4+ T cells are activated by MHC molecules binding with
the TCR and the CD28 co-receptor [90]. Once successfully activated, the naive T cells
produce effector T cells through clonal expansion and cell differentiation.
1.2.1.2 Effector T cell function and activation
Effector T cells respond to a variety of invading pathogens and are consequently con-
sidered to represent a heterogeneous cell population. The availability of co-stimulatory
complexes, antigen loads and cytokines determines the activation of T cells. Due to
deficiency in CCR7 and CD27, effector CD4+ T cells do not home in on lymph nodes.
Instead, they have other molecules which cause them to move to sites of infection. CD4+
effector T cells contain type 17 T helper (Th17) which produces interleukin (IL), i.e., IL-
12, IL-22 & IL-23, all of which induce immune responses against bacteria, fungi and tis-
sue inflammatory processes [18]. The regulation of effector T cells responses is necessary,
as overproduction of either Th1 or Th17 may result in organ-specific auto-immunity. Al-
lergies and asthma may also occur as a result of unregulated Th2 responses [118].
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1.2.1.3 Memory T cell function and activation
The adaptive immune system retains small numbers of long-lived memory T cells af-
ter an infection. This constitutes ‘immune-memory’ for pathogens enabling prolonged
pathogen immunity. Memory T cells respond with greater sensitivity and rapidity to
antigens than naive T cells. This is due to the higher proportion of antigen-specific
T cells as compared to varied naive T cells [56]. Memory T cells are subdivided into
two main subpopulations: central and effector memory T cells, (TCM and TEM respec-
tively). TCM which express CD62L and CCR7 are activated in response to secondary
antigen and move through the blood and secondary lymph nodes. TEMs do not express
CD62L and CCR7 and circulate through the blood and peripheral organs. TEMs are re-
sponsible for the secretion of cytokines and other cytolytic activities [9, 72, 113].
Various models have been proposed which describe the development of memory T cells.
These include: Linear differentiation, bifurcation and self-renewal models. First we con-
sider the linear differentiation model: This proposes that activated naive T cells produce
a large pool of effector T cells. Only a small proportion of these cells survive and dif-
ferentiate as long-lived memory T cells [56, 114]. The bifurcation model proposes that
the naive T cells divide ‘asymetrically’, i.e. one daughter cell produces effector cells,
while the other regulates the production of memory T cells [9, 17]. Studies have also
demonstrated that memory cell production can take place without antigen stimulation,
implying that naive T cells do not necessarily need to go through the activation phase
to become memory T cells [41, 79]. The self-renewal model proposes that naive T cells
differentiate directly into central memory T cells (TCM) and effector memory T cells
(TEM). TEM cells move to the inflammation sites and differentiate to become effector T
cells. These are illustrated in Figures 1.1(a, b and c).
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Figure 1.1: The three models for T cell differentiation. The diagrams are adapted from
Bains et al. [9].
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1.2.2 Maintenance and regulation of the T cell population
The T cell population is regulated and maintained through homeostasis which is respon-
sible for the addition or removal of thymic tissues [9]. Additionally, the expansion and
survival of the T cell population is due to its ability to reconstitute following immuno-
logical depletion [91]. Cell division, differentiation and survival are all homeostatically
regulated. However, the homeostatic effect is subtle, hindering our understanding of T
cells. The rate of thymic production and cells exported per day is not known. In vivo
thymectomy experiments have been used to investigate the dynamics of T cell popula-
tions in healthy human subjects [9].
It is well known that thymic involution occurs with advancement in age [7], although the
majority of prior studies have not shown any change in the overall thymic volume with
advancing age [9]. However, an age-related decline in the volume of TES, and growth
in adipose tissues, has previously been observed [99]. T cell receptor excision circles
(TRECs) are considered the principal thymic output marker. TREC numbers have been
shown to be significantly higher in children but decline with advances in age, and they
are also lower in HIV-infected people [7]. This is further described in Section 2.1.
Mathematical models recommend the use of TRECs/ml to measure blood thymic out-
put as opposed to TREC content per cell. This follows the notion that the decline in
the TREC population cannot be directly attributed to cell division. TRECs also influ-
ence thymic output through cell proliferation and cell loss through death or phenotypic
changes [32, 34].
1.2.2.1 Naive T cell homeostasis
Two processes are involved in naive T cell homeostasis, the stimulation of cytokines and
the interaction between self-peptide & MHC-TCR. These begin with the expansion and
release of large quantities of effector cells following activation by foreign antigens. Only
a small number of effector T cells survive this to become memory T cells [9, 101].
1.2.2.2 Memory T cell homeostasis
Studies have shown that the memory group develops from the naive T cell group, al-
though this process is not well understood [70]. Memory T cells undergo periodic self-
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replacement, supported by continuous induced expansion of antigens. The volume of
the memory T cell pool tends to remain constant in adults as opposed to children which
seems to increase from birth to a maximum during early year of life. Memory T cells ac-
quire new members through differentiation, while the pool is regulated through home-
ostasis. The division of memory T cells is faster than that of naive T cells in both healthy
children and adults [70, 94]. The survival and turnover of memory T cells is largely
influenced by MHC interactions. However, CD8+ T cells are capable of undergoing
homeostatic proliferation in the absence of MHC I. The memory T cell population is reg-
ulated through cell death, and this is compensated through production of new cells [9].
1.2.3 Age-related changes
The immune system grows from childhood to a relatively constant size in adulthood.
In longitudinal studies of T cell populations, it has been shown that CD4+ T cell num-
bers decline exponentially with advancement in age from birth to adolescence [38, 48].
At birth, CD4+ and CD8+ T cells constitute approximately 90% of the total naive T cell
population. However, with advances in age, the naive T cell population declines and
the ratio of naive to memory T cells approaches 1 : 1 at approximately 20 years. There-
after, the population of both naive and memory T cells remains relatively constant into
old age [36, 45, 48, 82]. Despite the reduction of the newly produced naive T cells in
the thymus, studies have shown that, on average, the number of T cell receptor (TCR)
sequences within naive T cells for individuals aged between 20 to 65 years are relatively
constant, but significantly higher in individuals older than 65 [9, 58].
1.3 Problem statements
In this study, we seek to address the following problems:
1. The loss of precision resulting from the practice of grouping age ranges into ‘blocks’
in cross-sectional studies that investigate changes in blood immunophenotypes.
2. The fitting of appropriate semi-mechanistic models to quantify blood lymphocyte
immunophenotypes in healthy children aged 2 weeks to 12.5 years.
3. Variation in the estimation of age-related changes in lymphocyte cell markers due
to population characteristics (covariate factors) of the study subjects.
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4. ‘Standardization’ of age-continuous, model-based methods for estimating refer-
ence ranges for lymphocyte cell markers.
5. The absence of a statistical package in R software to estimate age-continuous,
model-based reference ranges.
1.4 Objectives of the study
The fundamental aim of this study is to estimate model-based, age-continuous immune
biomarker reference ranges for healthy paediatric patients in South Africa. Specifically,
the study seeks to achieve the following objectives;
1. To fit single and double exponential models to the data and compare them in order
to produce improved models.
2. To investigate the influence of covariate factors on age-related changes in lympho-
cyte cell markers.
3. To propose and implement a more robust model-based, age-continuous method
for estimating reference ranges for lymphocyte cell markers. This will lead to de-
velopment of an R package for estimating model-based, age-continuous reference
ranges.
1.5 Project outline
In Chapter 2 we explore existing literature on mathematical and statistical models for
age-related changes in lymphocyte cell markers. We review available methods for ref-
erence range estimation and the possible biological factors which may influence such
changes. In Chapter 3 we present the comparison between double and single expo-
nential models, including their formulation, parameter-estimation and interpretation of
the results. In Chapter 4 we review the generalized nonlinear least squares estimation
method and extend the double exponential model to incorporate covariates. In Chapter
5 we present the new model-based, age-continuous estimation method, its implemen-
tation and results. We also compare this method with traditional centile curves. In
Chapter 6 we discuss and conclude this study, provide recommendations and areas for
future research.
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To construct reference ranges for immune biomarkers, the following are required; appro-
priate mathematical and statistical models for describing changes in lymphocyte popu-
lations, methods for describing normal reference ranges and an understanding of the in-
fluence of covariates within the population, on lymphocyte development. Below we re-
view foundational literature then modify historical reference range estimation methods
to develop our model-based approach. We also extend the double exponential model to
incorporate covariates.
2.1 Mathematical and statistical models for lymphocyte cell
markers
Both mathematical and statistical models are useful in studying immune system changes.
These generally involve simplifying assumptions regarding the system and provide a
means to evaluate the underlying biological processes.
2.1.1 Ordinary differential equation models (ODEs)
A variety of studies have employed ODEs to quantify and interpret immunological data
from in vivo studies [44, 46, 70, 76]. Such models are mechanistic in that they require bio-
logical assumptions to be made regarding the underlying mechanisms. In cases where
they have been used to estimate the rate of T cells division and death, they generally
assume that the cells divide and die at constant rates, respectively r and d, over time
period, t.
13
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Hazenberg et al. [44] developed an ODE model to describe T cell receptor excision circles
(TRECs) by studying two pools of cells; total naive T cells and total TRECs. Total naive
CD4+ T-cells at age t, N(t), is described by the following differential equation
dN(t)
dt
= θ(t) + ρ(t)N(t)− δ(t)N(t),
where θ(t) is the number of CD4+ T-cells exported per day at age t (the rate of thymic ex-
port), δ(t) represents the average rate of naive cell loss at age t (day−1) and ρ(t) denotes
per cell rate of addition to the naive population peripheral division at age t (day−1). The
authors assume that the rate of loss of TCR excision circle (TREC) content is homoge-
neous and that the average rate of naive CD4+ T cell loss is equal to the average rate of
TREC loss [8]. Under this assumption, the total naive TRECs with age is defined as
dT(t)
dt
= c(t)θ(t)− δ(t)T(t),
where T(t) is the total counts of naive TRECs in an individual at age t and c(t) is the
average naive TREC content of CD4+ T cells emerging from the thymus while δ(t) and
θ(t) remains as defined above.
Bains et al. [8] developed a dynamical mathematical model to quantify thymic export
by combining naive T cell proliferation and TREC models. The authors propose that
naive cell population is divided into compartments of resting and dividing naive cells,
as shown in Figure 2.1. Thymic export is expressed as a function of age from birth to 20
years, and the total number of naive T cells is then the sum of all cells within the resting
and dividing compartments. After the completion of each cycle, it is also assumed that
two daughter cells will move back to the resting pool.
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Adapted from Bains et al [7]
Figure 2.1: A simple model of naive CD4+ T cell dynamics. The model divides the
naive population into two components. Cell loss is caused by death, differentiation and
migration.
This model predicts a decline in the expression of Ki67, the protein specifically associ-
ated with cell proliferation, in naive CD4+ T cells and a rise in the rate of thymic export
during the first 12 months of life. This is attributed to immune system maturation and
increase in body growth in the first year of life (see Figure 2.2).
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Adapted from Bains et al [7]
Figure 2.2: Estimated number of naive CD4+ T cells generated by peripheral division
per day. Mean (solid line), 2.5% and 97.5% quantiles (dashed lines).
De Boer [28] also used ODEs to estimate the role of thymic output in HIV infection.
This model comprises two compartments, including the total number of naive T cells,
T, and those derived from the thymus, N. Cells produced in the thymus undergo cell
division and eventually die in the periphery leading to the disappearance of TRECs, T.
It is argued that cells produced in the thymus are dependent on the age of the person
and are also produced or die at a rate which depends on the total population of T cells.
Murray et al. [81] used ODE models to describe T cell homeostasis. The authors propose
two compartments, those originating from the thymus, N, and those that are proliferat-
ing (these are either naive T cells, Np, memory T cells, M and activate T cells, A). See
Equation 2.1.1.
N˙ = s0e−λtts(Np)−
(
λn + µng(Np)
)
N,
N˙p = λnN +
(
ch(N, Np)− µn
)
Np + λmn M,
M˙ = λa A− µm M− λmn M,
 (2.1.1)
where s0e−λtts(Np) is the T cells arising from the thymus, λnN lost into the proliferation
compartment and µng(Np)N die. The cells in the Np compartment result from incoming
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naive T cells λnN, proliferating cells ch(N, Np)Np and those lost by death, µnNp. Mem-
ory T cells, M, are reactivated cells λa A and are lost through re-conversion to naive T
cells, λmn M and death µM. The model predicts that the contribution of the thymus to
the overall CD4+ population at age 25 is approximately 20% per year. Further, this rate
decreases to 10% by the age of 40 and to 5% by the age of 55. They conclude that the
maintenance of naive T cells within the first 20 years of life is through thymic activity,
while after this age, it is through cell proliferation.
2.1.2 Statistical models
Both deterministic and stochastic models can be used to model age-related changes in
lymphocyte cell markers. Deterministic models will always produce the same output,
given the definition of initial parameter values. Stochastic models enable the introduc-
tion of randomness in the parameters. Randomness is produced by specifying a proba-
bility distribution for a parameter, which leads to slight variations in the outcome. Early
statistical studies of lymphocyte cell markers described changes by grouping particular
cell markers into ‘age-blocks’ and then used various tests to demonstrate differences be-
tween groups [24, 33, 50, 93, 95, 116]. Those which applied regression models to describe
such changes are of particular interest.
Wade and Ades [110] fitted age-related reference intervals using a maximum likelihood
estimation method on CD4 counts of uninfected children born to HIV-1 infected mothers
by using an exponential function with a Box-Cox transformation parameter. The Box-
Cox transformation ensures that the centiles are asymptotic and conform to the values
expected at older ages. Subsequently, they fitted a double exponential function to the
data using the LMS (lambda-mu-sigma) based maximum likelihood method. However,
the exact double exponential function was not disclosed [111]. The purpose of using
exponential models was to allow for the estimation of skewness, spread and to describe
the change in the median values of the CD4 counts. The authors used the likelihood ratio
test to compare and assess the statistical significance of the estimated model parameters.
A study in Malawi used regression analysis to estimate the linear association between
the healthy lymphocyte subsets with age [71]. Lymphocyte counts were log-transformed
and estimated cell numbers and percentages per sex category across various age groups,
although the study was not designed to explore sex differences in lymphocyte subsets.
Shearer et al. [95] used ordinary least squares linear regression on cross-sectional data
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of lymphocyte subsets in healthy children below 18 years.
Marie-Quitterie et al. [88] used a semi-mechanistic nonlinear regression model to in-
vestigate CD4 reconstitution in HIV-infected children. Their model proposes eventual
asymptotic stabilization of CD4 counts:
ln(yij) = βi − (βi − λi)ecitij ,
where ln(yi) are the CD4 counts for child i at time tij, λi is the count of CD4 at the
onset of the treatment, βi is the long-term ln(y) estimates, while ci is the proportional
recovery rate from λi to βi to occur. The CD4 counts, yi, are log-transformed to improve
normality. They then used least squares to fit the model to the data of individual subjects
followed by nonlinear mixed-effects modeling to account for inter-individual variability.
CD4 reconstitution was found to occur more rapidly in younger children. No significant
inter-individual recovery rate variability was found among subjects. Similar nonlinear
mixed-effects models have been used by Lewis et al. [66] and Claudia et al. [16].
Huenceke et al. [48] used a three parameter exponential model,
f (t) = c + b0(1− exp(b1t)), (2.1.2)
to describe lymphocyte development from childhood to adolescence. This model was
fitted using the minimization of the sum of squares of residuals. They also constructed
age-related reference ranges around the predicted values using Tukey’s method [48].
Profound age-related changes were found at early ages [31, 48]. Although they used an
age-continuous exponential function which eliminates the need for age-grouping, this
model did not account for the rise, following birth, with subsequent exponential decay
after one year of age that is normally empirically measurable in data of this type.
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2.2 Factors influencing age-related changes
Prior studies have shown that factors such as gender, age, ethnicity and lifestyle (e.g.,
alcohol use, smoking, diet and stress levels) may influence lymphocyte cell marker de-
velopment and quantities.
2.2.1 Age
In paediatric subjects, the immature immune system produces different numbers of
peripheral blood cell-surface markers compared to adults [29]. An adult has approx-
imately 3000 lymphocyte cell/ml in the peripheral blood, while in children, the number
of cell-surface markers rises from birth to a maximum (approximately 4000 lymphocyte
cell/ml) between six months [50] to one year of age [7], it then follows an exponential
decline as the child grows to adulthood. This is thought to be due to a number of inter-
related factors. For example, the progressive involution of the thymus in the first 20
years of life, exposure to antigens and the alteration of naive to memory cell ratios as-
sociated with immunological ‘learning’. Other factors include the rapid change in body
size and blood volume associated with growth and the progressive age-related replace-
ment of primary thymic production by peripheral cell division [29].
Various studies estimating reference values for peripheral blood lymphocytes have es-
tablished the effects of age. For instance, Choi et al. [20] classified healthy individuals
aged between 21 to 81 years-old into five groups. These include: 21-30, 31-40, 41-50,
51-60 and 61-80. They found statistically significant differences in the counts of CD3+,
CD3+CD8+ and CD3-CD56+ T cells between the these age groups. Similar findings
have also been reported in other studies [4, 20, 53] in which the aging effects have been
attributed to hematopoietic stem cell activities, thymic involution and the functional
decline in adaptive immunity.
2.2.2 Sex
Sex has been found to be a cause of differences in both innate and adaptive immune sys-
tems. In the innate system, males have less pronounced immune responses compared
to females [39]. The influence of sex includes differences in cell counts, cell activities
and levels of circulating cytokines. Females have been found to have relatively higher
phagocytic activities and more effective antigen presenting cells (APC). Males have been
shown to have higher activities of natural killer (NK) cells and increased levels of proin-
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flammatory cytokines [13, 14, 39].
In the adaptive immune system, females have higher percentages of circulating T lym-
phocytes than males. Further, in females, B cells and CD4 Th2 cells mainly drive im-
munological processes, while in men CD8 and CD4 Th2 cells are more dominant. No
differences between the sexes in the CD4/CD8 (Th/Tc) cell ratio have been found [39].
Differences in lymphocyte activities as a result of sex differences have been attributed
to hormonal, genetic and environmental factors and microchimerism [13, 39, 40]. Hor-
monal differences are caused by circulating steroids such as estrogen, progesterone and
testosterone, which influence various effector cells of the immune system. For example,
estrogen facilitates immune responses while progesterone and androgens reduce it [84].
A study conducted in a healthy Korean population observed significant differences be-
tween the sexes [20]. The percentages of CD3+ and CD3+CD4+ T cells were higher in
females. On the other hand, the percentages of CD3-CD56+ T cells were lower in females
than in males. Rudy et al. [92] established that females had higher counts of CD4+ T
cells, CD4+ memory T cells and lower CD16+ cells; higher mean totals of CD3+ and
CD4+. Other studies have also shown higher counts (or percentages) of CD4+ T cells
in females [11, 78, 103]. Such differences may be due to androgens or estrogen or both.
The differences between males and females starts during early development and be-
comes more pronounced at puberty, mainly due to the regulation and production of sex
steroids. The secretion of cytokines, as this influences cell proliferation, chemokines, B
and T cells accounts for further differences in T cells counts between males and females
[74, 85, 92, 100].
2.2.3 Race
The effects of race on immunological changes, in particularly healthy individuals, has
not been thoroughly investigated [60]. However, some studies have suggested that black
Africans have relatively lower rates of decline in CD4+ counts, compared to Caucasians,
possibly due to genetic differences [5, 35, 60]. Prior studies of normal reference ranges
conducted in large Chinese and Indian populations, with large socio-demographic di-
versity, have shown varying results [20]. For instance, an Indian study categorized the
population into Dravidian and Aryan ethnic groups, but found no significant differ-
ences in the mean values of the measured immune parameters [107]. Other studies also
found no association between ethnicity and the counts of CD4+ T cells [37, 97]. CD8+
and CD19+ cell counts have been found to vary gender and race [92].
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2.2.4 Food in the first 6 months following birth
Breast-milk contains antimicrobial and immunomodulatory components which protect
infants from pathogenic infections. This is primarily in the form of maternal immunoglob-
ulin A, which is responsible for mucosal respiratory immunity [106]. However, breast-
milk also contains lactoferrin, lysozyme and oligosaccharides which are antimicrobial
factors [64, 106, 117]. Breast-milk facilitates both short-term and long-term infant im-
mune system development. It has been shown that breast-fed children have enhanced
and longer duration immune protection against infections compared to formula-fed
children [106].
Breast-feeding is known to influence gene regulation, intestinal cell proliferation and
differentiation [6]. The bioactive factors in breast-milk catalyze the differentiation and
growth of B lymphocytes and initiate the production of particular antibodies. It also
contains pattern-recognition receptors for microorganisms, which are facilitated by the
presence of toll-like receptor (TLR) -2 and TLR-4, CD14 co-receptors and soluble CD14
[6, 62]. The composition of the mother’s breast-milk may vary depending on her age,
diet, ethnicity, weight gain or loss during pregnancy and the infant’s birth weight.
Studies of HIV transmission have established that exclusively breast-fed infants are at
a lower risk of mother-to-child transmission (MTCT) compared to mixed fed infants.
However, the risk of transmission of HIV to breast-fed infants increases by approx-
imately 20% for HIV positive versus negative mothers whose risk of transmission is
identically zero [83].
2.2.5 History of exposure to illness
Any historical exposure to viruses, bacteria or any other illness may lead to a compro-
mised immune system and a decrease in immune cell counts, such as of CD4+. The
rate and level to which cell counts drop depends on the duration of infection and the
ability of the immune system to fight it. For example, in newly diagnosed HIV-infected
people, CD4+ counts drop due to increased exposure to the virus. After initiation of
antiretroviral (ARV) therapy, CD4+ once again increases after the viral load has been
suppressed [55]. A proper understanding of the variability of lymphocyte cell markers
counts, which occurs in the absence or presence of HIV infection, is needed for both
CD4+ T-cells and all other blood lymphocyte subsets.
Studies of individuals with or without chronic illnesses have shown that psychological
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depression of any kind is associated with immune suppression. For example, in studies
of immunocompromised (HIV-seropositive) gay men, immunological changes in CD4+,
CD8+ and CD56+ cell counts and proliferative responses are associated with depression
[15, 57]. HIV positive women with symptoms of chronic depression are at twice the risk
of mortality compared to non-depressed women. Those most vulnerable have lower
CD4+ counts and higher viral loads [55].
Maternal health status has been found to be associated with increased morbidity and
mortality in infants. Higher perinatal transmission and disease progression is found
in infected infants born to HIV-positive women, particularly those at advanced disease
stages [1, 61]. Children born to HIV-seropositive women are at risk of acquiring HIV due
to direct or indirect utero or intrapartum viral exposure during birth and breast-feeding
[26, 27]. Kuhn et al. [61] established a significant association between infant mortality,
low CD4+ T cell counts and maternal hospital admission. Infants born to immunocom-
promised mothers may have inadequate passive immunity due to low trans-placental
transfer of IgG antibodies, which may lead to low counts of lymphocyte cell markers
[61]. Ota et al. [86] observed that exposure to HIV may compromise the development of
the foetal immune system, which may lead to non-immunogenic vaccination. A study
in Gambia [86] showed a reduced rate of formation of bacille Calmette-Guérin scarring
among HIV-negative infants born to HIV-infected women.
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2.3 Methods for constructing age-related reference ranges
Age-related reference intervals are employed in the monitoring and detection of depar-
tures from normality for clinical conditions that may indicate pathology. The reference
range is defined as 95% of the predicted population at a particular range. The remain-
ing 5% lie at the lower and upper (2.5% each) limits of the sample. Reference ranges
may also be understood as the representation of the intervals between two predeter-
mined centiles (commonly 5th and 95th) of a distribution of a variable, Y, drawn from a
‘healthy’ population at a given time (age). In reference to the concentration of immuno-
logical cell markers, higher or lower values of Y, above the upper limit or below the
lower limit represent abnormality, i.e.,
Abnormality =

Y lies below the lower limit,
Y lies above the upper limit.
Prior knowledge of the distribution of Y is fundamental in estimating the centile po-
sition of the individuals in relation to the reference population. The closeness of the
centile location (100% or 0%) measures the extremity of the observed Y. Establishing
reference intervals is based on the assumptions of log-normal or normal distributions.
Recent statistical methods have focused on the production of growth-charts, i.e. centiles
describing a smooth change over age [96]. According to Chitty and Altman [19], the
requirement of simplicity, which was key in the nineties, is becoming less important,
owing to improvements in computational technology. Methods for estimating reference
intervals include both parametric and non-parametric methods.
2.3.1 The clinical and laboratory standards institute (CLSI) approved
guidelines
A working group has published guidelines in view of the challenges associated with
empirically determining biomarker reference ranges, namely, the Clinical and Labora-
tory Standards Institute approved guideline (3rd edition) for defining and establishing
reference intervals [21]. Non-parametric and parametric methods were proposed. In the
former, the reference intervals are calculated by ranking n observations from smallest
to largest. Suppose that the rank of an observation is denoted by r, then the smallest
rank is r = 1 and the largest rank is r = n. The observations corresponding to the 2.5th
(corresponding to r1) and 97.5th (corresponding to r2) percentiles are r1 = 0.025(n + 1)
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and r2 = 0.975(n + 1) respectively. In the parametric method, suggested by Horn and
Pesce [47] and referred to as ‘robust’, the following is done: the location (centre) and
scale (spread) parameters are estimated, represented by median and median absolute
deviations (MAD) respectively. Then an iterative process of down-weighting actual ob-
servations, depending on their distance from the median, is performed. The median is
updated for each iteration until the difference between two consecutive medians is neg-
ligible.
The CLSI recommends the use of the non-parametric method owing to its apparent re-
liability, simplicity and the absence of any assumptions regarding the distribution of
the reference values. A key disadvantage is that it requires a minimum sample size of
120 individuals for the 95% reference intervals to be calculated. Small samples may re-
quire transformation (such as Box Cox) to eliminate kurtosis and since this involves the
weighted sum of observations, it increases susceptibility to the influence of outliers [43].
2.3.2 The LMS (lambda-mu-sigma) method and centile curves
Centile curves are the most commonly used method to estimate age-related reference
ranges. They are also used in medicine to compare the individual clinical measurements
to the population values. Such curves have been described as the "healthy empirical
model" that can be used for both diagnosis and comparison between healthy and un-
healthy individuals [25]. Centile curves are drawn from an underlying distribution and
obtained by splitting the population into different age groups. The shape of the curves
then provides information regarding skewness in the distribution [22].
The LMS method involves the parametrization by Box Cox transformation of the ob-
served variable with the three parameters L, M and S (λ, µ and σ) for skewness, the
median and the coefficient of variation respectively, for the variable of interest. Centile
curves are then constructed using the parameters [25, 96, 116] . The 100αth centile is
denoted by C100α(t) and is defined in (2.3.1).
C100α(t) = M(t)[1+ L(t)S(t)Zα]
1
L(t) , (2.3.1)
where Zα is the corresponding normal deviation for the tail area α; t is age in months;
C100α(t) is the Zα centile. This method accommodates various types of distributions,
whether normal, skewed or kurtotic. Although the LMS method produces convincing
centile curves, formal statistical inferences (other than location and shape), comparisons
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and appropriate formula for obtaining Z-scores remains problematic. The implementa-
tion of this method is also computationally intensive [116]. LMS and centile curves are
rigid in that the only parameters which can be estimated on the data are λ, µ and σ. Us-
ing semi-mechanistic or mechanistic models, which require the specification of additional
parameters to explain physical changes in the variable of interest or of covariates, does
not appear to be possible.
Wade and Ades [110] applied the Box-Cox transformation on CD4 lymphocyte counts
measured in blood samples of children. They used non-linear (negative exponential
power) models to approximate L, M and S parameters for the curves and then compared
the models using likelihood ratios. Although the estimated centile curves appeared to
fit the data well, the particular fitted functions were not provided. Although the LMS
method produces convincing centile curves, formal inferences for model comparisons
and appropriate formulae for obtaining Z-scores are not available.
2.3.3 Other approaches
Tsay et al. [104] propose a graphical method for estimating the standard deviation and
mean for log-transformed data. A two-parameter log-normal distribution is assumed,
and Q-Q plots are then used to obtain the reference limits through interpolation or ex-
trapolation depending on the sample size. This procedure has a subjective element in
that it is dependent on the validity of the log-normal assumption.
Lawrence, and Trewin [63], and Baughman et al. [12] propose parameter estimation
by maximum likelihood, using data modelled with a mixture of normal distributions.
Other methods assume a linear relationship between the centiles and ordered observa-
tions. Pearson correlation coefficients between corresponding sample fractions are then
used to define the reference intervals [110].
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Appropriate Models for Age-related
changes in lymphocyte cell markers
3.1 Introduction
Due to large variations in the measurements of the lymphocyte cell markers at young
ages in the South African paediatric data employed in this study, it is not clear on first
observation whether the age-related changes are best modelled using a simple negative
(single) exponential or a double exponential as previously described (see Section 2.1.2).
The formulation of such models is based on the following:
1. In all data sets, a general exponential decline with age is observed and a similar
trend has been observed and modelled on comparable European data [48].
2. But we also need to explore the possibility that we need to account for a transient
increase in biomarker levels among very young children. Prior empirical studies
have demonstrated that cell counts rise in the first year of life and then decline
exponentially thereafter [24, 95]. Mechanistic models of T-lymphocyte production
also predict a similar pattern [7, 111].
26
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3.2 Study data
3.2.1 Participants
Three hundred and eighty one (381) children aged from 2 weeks to 12.5 years were
recruited from a ‘Child Wellness Clinic’ (CWC) at a community health clinic in an infor-
mal settlement of Cape Town, South Africa [65]. The CWC was established primarily
as a research clinic, which also aimed to benefit the participants and the wider commu-
nity in terms of health promotion, education and screening. Attendance at the CWC
was voluntary, and the criteria for recruitment was that the child was well at the time
with no chronic medical condition or prescription medications, registered at the health
clinic, and attended with its biological mother and hand-held medical record. Mater-
nal HIV-exposure was not excluded. Informed consent was obtained in English or via
translator in Afrikaans or Xhosa. The session included clinical history and examina-
tion by a paediatrician, anthropometry plotting, assessment of vaccination status (and
catch-up as needed), provision of nutritional supplements and a food voucher. Each par-
ticipant had phlebotomy of 2-3mls of blood used for rapid HIV-antibody analysis (Alere
Determine®), full blood count (FBC) and basic immunological profile. HIV-infected chil-
dren were not included but were separately referred for treatment by the clinic. The
University of Stellenbosch granted ethical approval, (M12/01/005) and permission for
the study was given by Cape Town Department of Health.
3.2.2 Laboratory testing
Blood samples (in EDTA) were taken between 9am and 1pm, with 500µl of the origi-
nal samples couriered at room temperature by air to Johannesburg and processed the
following morning at the National Health Laboratory Service, Charlotte Maxeke Johan-
nesburg Academic Hospital (SANAS M0106B). Immunophenotypic analysis was per-
formed at the Johannesburg flowcytometry laboratory according to standard operat-
ing procedures. Directly labelled antibodies CD3 APC, CD3 FITC , CD16 PE, CD19
FITC, CD45 PerCP, CD45RO PE, CD45RA FITC, HLA Dr APC (Becton Dickinson Im-
munocytometry Systems (BDIS), San Hose, CA) , CD4 FITC, CD8 PE and CD56 PE
(Beckman Coulter, Inc. Miami, Florida) were added in pre-titrated manufacturer op-
timised concentrations to tubes with 50µl of well-mixed whole blood. Stained sam-
ples were vortexed once and incubated for 30 minutes. Red blood cells were then
lysed using FACS Lysing Solution (BDIS, San Hose, CA). All samples were run on a
Becton Dickinson FACSCalibur™ and acquired, and analysed, using CellQuest™ Pro
software. Prior to analysis, basic daily flow cytometer set-up included assessment of
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Calibrite™ 3 and Calibrite™ APC beads (BDIS, San Hose, CA) to monitor laser, optics,
fluidic alignment, linearity and instrument performance for the FACSCalibur™, accord-
ing to the manufacturers’ standards. Listmode data were stored for retrospective analy-
sis. External CD4 Quality Assessment for CD4 testing was performed through the U.K.
NEQAS Immune Monitoring scheme and the NHLS CD4 African Regional External
Quality Assessment Scheme [65]. Lymphocyte subsets were expressed as a proportion
of total lymphocytes determined using bright CD45 expression and side scatter. Spe-
cific lymphoid subsets assessed included: total CD3, CD3+/CD4+, CD3+/CD8+, CD3-
/CD56+, CD16+/56+, CD3+/HLA Dr+, CD3+/CD4+/HLA Dr+, CD3+/CD8+/HLA
Dr+, CD3+/CD4+/45RA+, CD3+/CD4+/45RO+, CD3+/CD8+/45RA+, CD3+/CD8+/45RO+
and total CD19. Absolute cell counts were obtained using a dual platform method; total
lymphocyte counts on all samples were obtained on a Beckman Coulter LH750 haema-
tological analyzer. All laboratory work and data analysis were performed by technician
blinded to the patients. In this study we describe seven lymphocyte cell markers. These
include: CD3+, CD19+, CD8+, CD4+, ratio of CD4+ naive/memory, CD16+CD56+
and CD3−CD56+.
Table 3.1: Explanation of cell-markers investigated in this study.
Cell-surface markers Cellular Expression Functions
Thymocytes, T-cells Associated with the T cell receptor (TCR).
CD3+ Small amounts in Purkinje cells Required for cell surface expression and signal transduction by TCR.
Thymocytes, Helper T-cells Sends signal to other immune cells (CD8 and killer cells).
CD4+ Inflammatory T-cells Co-receptor for MHC class II molecules.
About 2/3 of the peripheral T-cells Binds lck on cytoplasmic face of membrane.
Receptor for HIV-I and HIV-2 gp120.
CD4+ counts are used to determine when to start HIV therapy.
Thymocyte subsets, cytotoxic T-cells Co-receptor for MHC class I molecules.
CD8+ About 1/3 of the peripheral T-cells Binds lck on cytoplasmic face of membrane.
B cell co-receptor in conjunction with CD21 and CD81.
CD19+ B cells Required for binding of Src-family, kinases and recruitment of PI-3 kinase .
Diagnosis of cancers arising from B-cell lymphomas.
Component of low affinity Fc receptors, FcγRIIIa (CD16a) and FcγRIIIb (CD16b).
CD16+ Natural killer cells, macrophages These Fcs mediates phagocytosis and antibody-dependent cell-mediated
cytotoxicity (ADCC).
CD56+ Natural killer cells An isoform of Neural Cell Adhesion Molecule (NCAM) which signals to induce
neurite outgrowth via the Fibroblast growth factor receptor (FGFR).
Adapted from [2, 115]
The data generated from the 381 SA children was entered into Microsoft Excel (2010).
The immunophenotypes counts was then tabulated by age. Data analysis was per-
formed using R statistical software (version 3.2.3).
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3.3 Methods
3.3.1 Formulation of models
The models are semi-mechanistic, and assume that cell markers either decrease exponen-
tially from birth, or alternately rise from birth to a maximum at 12 months and then
decline to an asymptote with advancing age. Specifically:
3.3.1.1 The single exponential model
This is a simple three parameter model, mathematically equivalent to that applied by
Huenceke et al. [48]:
f1(t) = β0 + β1 exp(−β2t), (3.3.1)
where the sum of β0 and β1 is the estimated cell count at birth while β2 is the rate of
change in cell markers over time. From the graph of this function, showed in Figure 3.1
in green, it assumes a simple exponential decline from birth.
3.3.1.2 The double exponential model
This model is formulated from the single exponential model by adding a fourth param-
eter β3 and then multiplying (3.3.1) by 11+exp(−β3t) . The resulting function is defined
as
f2(t) =
β0 + β1 exp (−β2t)
1+ exp(−β3t) . (3.3.2)
The average of β0 and β1 estimates the cell count at birth (t = 0), β2 estimates the rate of
change of cell markers over time while (β3) determines the shape of the curve. For large
values of t, the function reduces to the single exponential model described above and
thus β0 estimates the cell count at large t’s, i.e. older ages. This function, when plotted,
rises and then descends to an asymptote as t increases, as shown in Figure 3.1 in blue.
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Figure 3.1: A comparison of the formulated models. Model 1 (the single exponential)
showed an exponential decay immediately from birth, Model 2 (the double exponential)
demonstrates an exponential growth from birth followed by an exponential decline.
3.3.2 Parameter estimation
In the two models, we assume that the parameters are associated with the population,
rather than individuals, as the data is cross-sectional in nature.
Definition 3.3.1. Given predictor values t1, t2, · · · , tn and the observed values Yi, where i =
1, · · · , n, the unknown mean function, µ(t) = E(yi|ti), can be approximated by a parametric
functions f j, j = 1, 2. These functions are formally called regression functions. Define
Yi = f j(ti, β) + ei,
where the unknown, β, is a vector of parameters in f j and t is the predictor variable.
The random error, ei, by construction, is the difference between the observed Y and the
mean functions f j(t, β). We assume that E(ei) = 0 and var(ei) = σ2i . The goal is to
estimate the unknown parameter β by minimizing the distance between the observed
Y and f j(t, β). The nonlinear least squares method aims at obtaining the estimates of β
that minimizes the residual sum of squares (SSR) defined as
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S(β) =
n
∑
i=1
(
Yi − f j(ti, β)
)2. (3.3.3)
Let βˆ be the solution of (3.3.3), then βˆ is called the least square parameter estimate of β.
Suppose we assume homogeneity in the variance of ei and let this value to be var(ei) =
σ2, then the estimated variance is given by
σˆ2 =
S(βˆ)
n
. (3.3.4)
Considering (3.3.3), we obtain the solution set for the parameters βˆ j from the partial
derivative with respect to βk, k = 0, 1, 2., if f j, j = 1 and βk, k = 0, 1, 2, 3, if f j, j = 2
equated to zero, i.e.,
∂S(βk)
∂βk
= −2
n
∑
i=1
(
Yi − f j(ti, β)
)∂ f j(ti, βk)
∂βk
=⇒ − 2
n
∑
i=1
(
Yi − f j(ti, β)
)∂ f j(ti, βk)
∂βk
= 0 (3.3.5)
This is referred to as nonlinear least squares (nls). Due to the nonlinear nature of f j(ti, β),
the solution to (3.3.5) cannot easily be explicitly obtained. However, iterative numerical
procedures such as the Gauss-Newton algorithm may be used for this (see discussion
by Huet [49] and Bates & Pinheiro [89]). Here, Yi, i = 1, 2, · · · , n, are the counts of the
lymphocyte cell markers corresponding to particular ages represented by ti of subject i.
3.3.2.1 Modelling heteroscedasticity
One of the underlying assumptions in modelling is that of equal variances of data points
about the deterministic part of the model (fitted values). In other words, the deviations
of the error terms in the regression model are constant across all the explanatory vari-
ables. However, this assumption normally fails, and did so in the present case. Het-
eroscedasticity is present when the magnitude of the error term is variable within the
predictor variable. Mathematically, heteroscedasticity is defined as
var(ei) = σ2i .
Weights in generalized nonlinear least squares were used to address this problem. Weights
were expressed as the power-of-the-mean (fitted) response (varPower()) in gnls [89]. Plot-
ting the data revealed that the variance structure around the expected mean function
declined with advancing age (see Figure 3.2). Weights are defined as
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σ2i = σ
2g(ti, β, τ) = σ2 f j(ti, β)τ.
To estimate the above parameters, the generalized nonlinear least squares gnls library
in the NLME package in the R environment was used, specifically because of the het-
eroscedastistic variance structure and the non-linear mean function.
3.3.3 Model comparison and selection
In this study, we used the likelihood ratio test, Akaike’s Information Criterion (AIC) and
the Bayesian Information Criterion (BIC).
3.3.3.1 Likelihood ratio test
The likelihood ratio test is used to compare nested models. Let β1 denote the set of
estimated parameters from the less restricted model and β2 denote the set of estimated
parameters for the restricted model. Then the likelihood ratio is defined as
LR = 2log
[
L(β1)
L(β2)
]
= 2[logL(β1)− logL(β2)].
LR ∼ Xp, where p is the degrees of freedom.
3.3.3.2 Information criteria
Suppose we have nested models M1, · · · , Mq which we wish to compare. We rank the
models M1 ≺ M2 ≺ · · · ≺ Mq in terms of their complexity, so that Mi ≺ Mj, i, j =
1, 2, · · · , q. The most common methods which are based on information criterion are
the AIC and BIC which combines both the model complexity and the given number of
parameters.
a) Akaike’s Information Criterion (AIC)
This method was proposed by Akaike in 1973 following the works by Kullback-
Leibler information for model selection [73]. The AIC is defined as
AIC = −2(loglikelihood) + 2p,
where p is the number of the estimated parameters included in the model. Lower
AIC values indicate better model. To compare the models, delta AIC and Akaike
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weights were obtained. The delta AIC is defined as
Akaike ∆i = AICi −minAIC
while the Akaike weights are defined as
Akaike wi =
exp(−0.5∆i)
∑Mr=1 exp(−0.5∆r)
.
Alkaike weights represents the ratio delta AIC for each model relative to the col-
lection of candidate models and provides the strength of evidence for each model.
They indicate the probability that the model is the best among the whole set of
candidate models. The interpretation is simple, i.e. the greater the weight, the
better the model [73].
b) Bayesian information criterion (BIC)
BIC, similar to the AIC, assesses the overall fit of a model and can be used to
compare both nested and non-nested models. It identifies the model which is most
to have generated the data. The BIC is defined as
BIC = −2(loglikelihood) + plog(n)
The criteria for model comparison using BIC is the same as for the AIC,
Bayesian ∆i = BICi −minBIC.
∆i provides the evidence against model i.
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3.4 Results
Figure 3.2 provides a summary of empirical changes in three lymphocyte cell markers
(CD19+, CD8+ and CD3+) by age-grouping. The ‘age-blocks’ are the same as those
applied by Comans-Bitter et al. [24] and Shearer et al. [95].
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Figure 3.2: The current data represented using the Comans-Bitter et al. [24] and Shearer
et al. [95] ‘age-blocks’. For CD19+ and CD8+ the markers clearly increase in the first 12
months and then decline thereafter. In the case of CD3+ the trend is also present but less
pronounced.
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3.4.1 Parameter estimates
Model parameters were estimated using weighted gnls for the CD3+, CD19+, CD8+,
CD4+, the ratio of CD4+ naive/memory, CD16+CD56+ and CD3-CD56+ groups:
Table 3.2: Comparison of parameter estimates for the two models.
Double Exponential Model Single Exponential Model
Lymphocytes Parameters Estimates 95% Confidence Interval p-value Estimates 95% Confidence Interval p-value
β0 1838.114 (1674.603, 2001.625) 0.000 1665.714 (1419.235 , 1912.192) 0.000
CD3+ β1 6390.389 (5240.055 , 7540.723) 0.000 3218.810 (2878.038 , 3559.582) 0.000
β2 0.047 (0.040, 0.055) 0.000 0.026 (0.019 , 0.033) 0.000
β3 0.108 (0.045, 0.171) 0.001
β0 308.142 (259.398, 356.885) 0.000 279.957 (216.938 , 342.975) 0.000
CD19+ β1 1776.413 (1201.939, 2350.888) 0.000 1285.270 (1131.061 , 1439.479) 0.000
β2 0.038 (0.028, 0.048) 0.000 0.028 (0.021 , 0.035) 0.000
β3 0.207 (-0.029, 0.442) 0.085
β0 728.810 (643.107, 814.512) 0.000 588.653 (437.002 , 740.305) 0.000
CD8+ β1 1384.083 (809.443, 1958.723) 0.000 1004.887 (840.705 , 1169.069) 0.000
β2 0.038 (0.023, 0.054) 0.000 0.021 (0.011 , 0.031) 0.000
β3 0.223 (-0.019, 0.464) 0.071
β0 1127.695 (1008.358 , 1247.032) 0.000 1070.594 (935.140 , 1206.048) 0.000
CD4+ β1 4988.450 (4260.474 , 5716.426) 0.000 2174.424 (1940.508 , 2408.341) 0.000
β2 0.050 (0.035 , 0.064) 0.000 0.032 (0.024 , 0.040) 0.000
β3 0.061 (0.006 , 0.116) 0.030
β0 1.025 (0.737 , 1.314) 0.000 0.925 (0.597 , 1.253) 0.000
Ratio CD4+ naive/memory β1 2.788 (2.332 , 3.244) 0.000 2.606 (2.259 , 2.953) 0.000
β2 0.026 (0.015 , 0.037) 0.000 0.021 (0.013 , 0.030) 0.000
β3 0.874 (0.200 , 1.549) 0.011
β0 265.371 (217.848 , 312.894) 0.000 259.848 (206.680 , 313.016) 0.000
CD16+CD56+ β1 1012.223 (651.045 , 1373.402) 0.000 432.207 (316.128 , 548.286) 0.000
β2 0.057 (0.023 , 0.092) 0.001 0.038 (0.017 , 0.060) 0.000
β3 0.074 (-0.065 , 0.213) 0.295
β0 335.200 (-1948.868 , 2619.268) 0.773 260.010 (209.763 , 310.256) 0.000
CD3−CD56+ β1 1031.178 (-1055.107 , 3117.462) 0.332 429.836 (312.918 , 546.753) 0.000
β2 0.036 (-0.012 , 0.084) 0.138 0.040 (0.018 , 0.062) 0.000
β3 0.010 (-0.230 , 0.250) 0.936
All the parameter estimates for all markers using the single exponential model were
statistically significant (at alpha = 0.05). In the double exponential model, the esti-
mate of the additional β3 parameter was not statistically significant for CD19+, CD8+,
CD18+CD56+ and CD3-CD56+, thus, there is no reason to prefer the double exponential
model. Although, the double exponential model is not as likely as the single exponen-
tial, but contains more inherent information.
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Little ‘structural’ differences are visible in the overall fits of the two models, as shown
in Figures 3.3.
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Figure 3.3: Plots showing changes in absolute counts of CD3+, CD4+, CD8+ and CD19+
over time for healthy South African children. For CD3+, CD8+ and CD19+, the double
exponential model predicts a rise in the counts of cell makers from birth to about 12
months followed by an exponential decline to older ages. This pattern is less apparent
for CD4+.
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Figure 3.4: Plots showing changes in absolute counts of ratio of CD4+ naive to memory
T cells, CD16+CD56+ and CD3-CD56+ over time for healthy South African children.
For the ratio of CD4+ naive to memory T cells, the double exponential model predicts
an initial rise in the counts from birth to about 12 months followed by an exponential
decline. For CD16+CD56+ and CD3-CD56+, the prediction for the double exponential
model is similar to that of the single exponential model and thus either of the models is
preferred.
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3.4.2 Models-fit comparison and assessment
For CD3+, CD19+, CD8+, CD16+CD56+ and CD3 CD56+ the double exponential model
had higher AIC-weights of 0.998, 1.000, 1.000, 0.790 and 0.820 respectively. The single
exponential model had higher AIC-weights in ratio of CD4+ naive/memory (0.650) and
for CD4+ (0.540).
Table 3.3: Log-likelihoods and AIC for the two fitted models
Lymphocytes Model Loglik δ Loglik AIC δ AIC AIC weight
2 -3209 7.5 6430.2 0.0 0.998
CD3 + 1 -3216.5 0.0 6443.2 13.0 0.002
2 -2861.9 21.6 5736 0.0 1.000
CD19 + 1 -2883.5 0.0 5777.1 41.1 < 0.001
2 -2926.5 18.6 5865.2 0.0 1.000
CD8 + 1 -2945 0.0 5900.2 35.1 < 0.001
1 -3046 0.0 6102.2 0.0 0.540
CD4 + 2 -3045.2 0.9 6102.5 0.3 0.460
1 -590 0.0 1190.1 0.0 0.650
Ratio CD4+ naíve/memory 2 -589.6 0.4 1191.3 1.2 0.350
2 -2736.4 2.3 5485.1 0.0 0.790
CD16+CD56+ 1 -2738.8 0.0 5487.7 2.6 0.210
2 -2728.1 2.6 5468.4 0.0 0.820
CD3−CD56+ 1 -2730.7 0.0 5471.5 3.1 0.180
*Model 1 refers to the single exponential model while Model 2 refers to the double exponential
model. Higher AIC-weight implies better model.
Overall, based on the information content and the AIC the double exponential may be
considered the better of the candidate models. In assessing the quality of generalized
nonlinear least squares (gnls) fits we consequently focus our analysis on the double ex-
ponential model from this point forward. As shown in Figure 3.5, plots of residuals
versus fitted values are used to assess the adequacy of the heteroscedastic fit. For most
of the markers, the standardized residuals are symmetrically distributed around the
zero line, with fairly uniform variance. This indicates that the power variance model we
employed adequately models the heteroscedasticity for the majority of the markers.
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Figure 3.5: Plots of standardized residuals against the fitted values to assess het-
eroscedasticity using gnls for the double exponential.
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The correlation of the error terms are assessed using empirical autocorrelation func-
tion plots shown in Figure 3.6. No significant autocorrelations between the residuals are
visible. For some cell markers, in some lags, the autocorrelations were slightly outside
the 5% significance (lower and upper critical) levels, but this does not seem sufficient to
conclude that the errors are non-random.
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Figure 3.6: Plot of empirical autocorrelation function for standardized residuals to assess
the correlation of the errors for the double exponential model using gnls.
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3.5 Summary
Our analysis demonstrated that age-related changes in count of peripheral blood lym-
phocyte cell-markers (immune biomarkers) with advances in age were present for all
markers investigated. In all cases, in the first year of life, the population count of lym-
phocyte cell marker was larger compared to that at greater age. This finding is in agree-
ment with prior studies [8, 48, 50, 69, 93, 105]. For some markers the nature of the
change in the first year was not clear. For this reason, two models were fitted to the
data to determine which of them provided the mathematically better fit. Both models
demonstrated relatively similar fits and also provided continuous predictions over time
(age). The single exponential model predicts that the absolute count in the mean popu-
lation of the blood lymphocyte cell markers only declines from a maximum at birth to
an asymptote in adulthood. This trend is the same as that proposed by a prior European
study [48]. On the other hand, our double exponential model predicts a rise in absolute
count to a maximum at approximately 12 months of age followed by an exponential de-
cline thereafter. The latter findings agree with prior mechanistic models and empirical
study measurements in the young age reference ranges [8, 24, 33, 95, 111]. Our dou-
ble exponential model also incorporates to some extent the single exponential model in
that it reduces to its mathematical form under particular conditions. The mathematical
and statistical comparison between the two models also singled out the double expo-
nential as the best in predicting the change in cell markers with age, as seen in higher
AIC-weights for most of the cell markers in the case of double exponential model.
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The influence of covariate factors on
Age-related changes in lymphocyte
cell markers
4.1 Introduction
An important function of circulating blood lymphocytes is the regulation of immune
homeostasis. Invasive pathogens may affect the immune balance which might lead to
immune-related disorders. Quantifying lymphocyte cell markers is important in eval-
uating disease progression and optimizing treatment interventions [20]. Regional, i.e.
African and international, variations in cell marker quantities have been attributed to
differences in age, sex, ethnicity, altitude, diet, endemic infections, autoimmune condi-
tions and the testing methodologies employed [4, 13, 20, 39, 60].
In HIV, various factors have been found to be associated with low CD4 counts, such
as age, sex, ethnicity and geographic region. Patients undergoing ARV therapy with
low CD4 counts have been shown to be at high risk of acquiring opportunistic infec-
tions. Other factors such as treatment adherence, immmunosuppressive drugs, socio-
economic and psychosocial factors are correlated to CD4 T cell counts in both HIV posi-
tive and negative patients [77]. In this chapter, we investigate the influence of covariate
factors for healthy South African children.
42
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4.2 Methods
In this section we extend the double exponential to incorporate covariate factors and
describe the parameter estimation methods.
4.2.1 Generalized nonlinear least squares
Mixed effects models are useful in determining the relationships between variables of
interest and covariates which may be grouped according to at least one classification
factor (covariate levels). Longitudinal or repeated measurement data is required for
mixed effects models, which model the variance-covariance structure of within-group
dependencies. In the present case, we only have cross-sectional data with covariates as
the only grouping factors. We consequently apply an extended generalized nonlinear
least squares regression, a simplification of nonlinear mixed effects, to model within-
group variance-covariance structure without random effects [89], i.e. the current models
are at a population level only.
Considering the ith observation in the jth covariate group, the extended nonlinear least
squares is defined as
yij = f (θij, bij) + eij, i = 1, · · · , nj; j = 1, · · · , m. (4.2.1)
θij = Aijβ,
where bij are the covariates, θij are the parameters, m is the number of covariate groups
and eij are the normally distributed error terms. The generalized nonlinear least square
(gnls) which does not involve two-stage modeling, described in Equation 4.2.1, by the
covariate grouping parameters θij, is defined as
yi = fi(θi, bi) + ei
θi = Aiβ, ei ∼ N(0, σ2∆i).
Inference and estimation of this model is through generalized nonlinear least squares.
The transformation suggested by Thisted [102] and Pinheiro & Bates [89] on this model
leads to the ‘classic’ nonlinear regression model defined as
y∗i = f
∗
i (θi, bi) + e
∗
i (4.2.2)
θi = Aiβ, e∗i ∼ N(0, σ2 I).
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Parameters in 4.2.2 are estimated using both maximum likelihood and least squares. By
letting N be the total observations, the log-likelihood function of a gnls model is defined
as
l(θ, σ2|y) = −1
2
[
N log
(
2piσ2
)
+
M
∑
i=1
(
(y∗i − f ∗i (θi, bi))2
σ2
+ log(∆i)
)]
. (4.2.3)
Define f ∗i (β) = f
∗
i (θi, bi), where β is a fixed parameter. Also let λ be the profile log-
likelihood estimator, then the maximum likelihood estimator of σ2 is given by
σˆ2(β,λ) =
M
∑
i=1
(
(y∗i − f ∗i (β))2
N
)
. (4.2.4)
We replace f ∗i (θi, bi) with f
∗
i (β) and σ
2 with σˆ2(β,λ) in Equation 4.2.3 to obtain the
profile log-likelihood defined as
l(β,λ|y) = −1
2
[(
Nlog
(
2pi
N
)
+ N
)
+ log
(
M
∑
i=1
(y∗i − f ∗i (β)2
)
+
M
∑
i=1
log(∆i)
]
. (4.2.5)
Pinheiro and Bates [89] describe the Gauss-Seidel algorithm for obtaining maximum
likelihood estimates for β and λ from Equation 4.2.5. The computational method uses
restricted maximum likelihood estimation (REML), thus, the estimate of σ2 in Equation
4.2.4 becomes
σ˜ =
M
∑
i=1
(
∆ˆ
−T
2
i
(yi − fi(βˆ))2
(N − p)
)
,
where p is the number of parameters.
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4.2.2 Extending the double exponential model
We incorporate the covariates into our model by extending the double exponential model
3.3.2 described in 3.3.1.2 and then describe model fitting process.
4.2.2.1 Adding covariates
To investigate the influence of covariates on the overall age-related changes of the lym-
phocytes, the parameters β0, β1, β2 and β3 are adjusted as a sum of the intercept term
and the covariate effect sizes. We are interested in observing the differences at birth and
changes with advancing age. The average of β0 and β1 gives the expected cell counts
at birth. We then assume that effects on either β0 or β1 implies an effect on the average
of the two. β2 estimates the rate of cell decline over time. Further, we assume that the
shape parameter, β3, is the same across the covariates. Therefore, we only adjust β0 and
β2.
We define Ω as the combined effect sizes of the covariates. It follows that Ω can be
expressed as a linear combination of the covariates. Let G represent sex (female = 0,
male = 1), R represent race (African black = 0, Mixed race/Coloured = 1), E represent
history of exposure to illness (No history of exposure = 0, history of exposure = 1), and
F represents the type of feeding within the first six months following birth (exclusive
breast feeding = 0, bottle feeding = 1, mixed feeding = 2). Then the terms incorporating
covariates are defined as
Ω0 = γ0Gg∈{0,1} + α0Rr∈{0,1} + τ0Ee∈{0,1} + φ0Ff∈{0,1,2}
Ω2 = γ2Gg∈{0,1} + α2Rr∈{0,1} + τ2Ee∈{0,1} + φ2Ff∈{0,1,2},
where γi, αi, τi and φi, i = 0, 2, are the effect sizes as a result of incorporating sex, race,
history of exposure and feeding, respectively, into the model. Therefore, we define the
extended double exponential as
f ∗(t, β,Ω) =
(β∗0 +Ω0) + β1 exp (−(β∗2 +Ω2)t)
1+ exp(−β3t) , (4.2.6)
where f ∗(t, β,Ω) is the expected cell count at age t, the average of (β∗0 + Ω0) and β1
estimates the cell counts at birth (t = 0), (β∗2 +Ω2) estimates the rate of change of cell
markers over time while β∗0 and β∗2 are the estimated intercept vales for β0 and β2 as a
result of the adjustment.
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4.2.2.2 Parameter estimation using gnls
The extended model describing lymphocyte counts cell markers yij in the jth covariate
at age i, where j represents the 4 covariates described above is then redefined as
yij =
(β∗0 +Ω0) + β1 exp (−(β∗2 +Ω2)ageij)
1+ exp(−β3ageij) + eij, (4.2.7)
The parameters β∗0, β1, β∗2, β3 and covariate adjustment parameters γi, αi, τi and φi,
i = 0, 2 are estimated using using generalised nonlinear least squares (gnls) described
above and implemented in library gnls in the nlme package in R.
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4.3 Results
4.3.1 Descriptives
The population characteristics and covariates for the healthy South African children are
presented in Table 4.1.
Table 4.1: Characteristics of the study population.
Characteristics N Percentage
Children 381 100%
Sex
Male 174 46%
Female 207 54%
Race
Black 85 22%
Coloured 296 78%
Food in the first 6 months following birth
Bottle 46 12%
Mixed 103 27%
Breast 231 61%
History of Exposure to Illness
Exposed 162 43%
Not Exposed 219 57%
*1 respondent had no information on type of food during 6 months.
History of exposure to illness included maternal HIV-status, antena-
tal/neonatal/past medical event requiring admission or recent infec-
tion within last month.
The mean age of the children was 32.08 (sd = 34.9) months, minimum and maximum
age was 0.62 and 151.33 months respectively. 54% of the subjects were female, with a
mean age of 31.19 months, a minimum age of 0.62 and a maximum of 147.41 months.
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4.3.2 Model prediction comparisons and extended model estimates
4.3.2.1 CD3+ T cells
Figure 4.1 shows a comparison of independently predicted counts of CD3+ for each of
the investigated covariates.
1. Sex and history of exposure to illness: Female subjects had higher predicted cell
count than males at almost all ages. The same was observed for maternal exposure
to illness. Those who had previous exposure had increased predicted cell counts
at birth compared to those who had not.
2. Race: There was no major difference in the trends of predicted CD3+ T cells counts
between African blacks and Mixed Race/Coloured children.
3. Type of food: Children who were fed on bottle feeds had higher and lower pre-
dicted cell counts at birth and older ages respectively, compared to the other two
groups. Breast-fed children had slightly higher counts at birth and older ages com-
pared to those with mixed-feeding.
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Figure 4.1: A plot showing age-related changes in CD3+ T cells across the different
covariates.
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When using independent predictions for the covariates some differences were observ-
able in the figures. However, in the extended model, the covariates had no statistically
significant influence on age-related changes in the counts of CD3+ cell markers (Table
4.2).
Table 4.2: Parameter estimates for the extended model with CD3+.
Estimate 95% Confidence Interval p-value
β1 6373.047 [5178.343, 7567.752] 0.000
β3 0.114 [0.045, 0.183] 0.001
β0
β0.(Intercept) 2146.510 [1617.890, 2675.130] 0.000
γ0.(Sex - Male) -197.740 [−508.784, 113.303] 0.212
α0.(Race - Coloured) -150.512 [−606.080, 305.057] 0.516
τ0.(Exposure - Exposed) 18.339 [−299.076, 335.754] 0.910
φ0.(Feeding - Bottle) -302.435 [−788.300, 183.430] 0.222
φ0.(Feeding - Mixed) -220.855 [−598.793, 157.084] 0.251
β2
β2.(Intercept) 0.063 [0.041, 0.085] 0.000
γ2.(Sex - Male) -0.006 [−0.018, 0.006] 0.295
α2.(Race - Coloured) -0.009 [−0.027, 0.009] 0.331
τ2.(Exposure - Exposed) 0.000 [−0.012, 0.012] 0.962
φ2.(Feeding - Bottle) -0.011 [−0.027, 0.006] 0.207
φ2.(Feeding - Mixed) -0.011 [−0.025, 0.003] 0.112
*The reference groups are: females for sex; blacks for race; non-exposed for his-
tory of exposure to illness and breast-feeding for type of feeding during 6 months
following birth.
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4.3.2.2 CD4+ T cells
Figure 4.2 shows a comparison of independently predicted counts of CD4+ for each of
the investigated covariates.
1. Sex: At birth, female subjects demonstrate higher cell counts compared to males.
All male subjects have an initial rise in cell counts from birth to a maximum at 12
months followed by exponential decline.
2. History of exposure to illness: During early life, subjects that had no maternal
exposure to illness had increased cell counts compared to those who were previ-
ously exposed. All previously exposed subjects had an initial rise in cell counts
from birth to a maximum at 12 months followed by an exponential decline.
3. Race: Black children had slightly increased predicted counts at birth and older
ages versus Mixed race/Coloured subjects. For black children there was an ex-
ponential decline immediately from birth while for coloured children, cell counts
initially rose to approximately 12 months and then declined thereafter.
4. Type of food: Children who were bottle-fed had higher and lower predictions of
cell counts at birth and older ages respectively, compared to the other two groups.
Breast-fed children had slightly higher counts at birth and older ages compared
to those fed on mixed meals. Breast-fed children had an initial rise in cell counts
followed by an exponential decline.
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Figure 4.2: A plot showing age-related changes in CD4+ T cells across the different
covariates.
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The extended model estimates did not show any significantly different effect sizes ver-
sus independently estimated predictions for the covariates for CD4+ (Table 4.3)
Table 4.3: Parameter estimates for the extended model for Age-related changes in CD4+.
Estimate 95% Confidence Interval p-value
β1 4857.763 [4088.510, 5627.015] 0.000
β3 0.079 [0.021, 0.137] 0.008
β0
β0.(Intercept) 1384.107 [1056.467, 1711.747] 0.000
γ0.(Sex - Male) -187.005 [−381.902, 7.893] 0.060
α0.(Race - Coloured) -147.640 [−429.455, 134.174] 0.304
τ0.(Exposure - Exposed) 59.952 [−137.843, 257.747] 0.552
φ0.(Feeding - Bottle) -218.728 [−516.265, 78.809] 0.149
φ0.(Feeding - Mixed) -76.213 [−307.224, 154.798] 0.517
β2
β2.(Intercept) 0.069 [0.043, 0.095] 0.000
γ2.(Sex - Male) -0.005 [−0.017, 0.007] 0.407
α2.(Race - Coloured) -0.013 [−0.031, 0.006] 0.182
τ2.(Exposure - Exposed) 0.005 [−0.007, 0.018] 0.394
φ2.(Feeding - Bottle) -0.011 [−0.027, 0.005] 0.166
φ2.(Feeding - Mixed) -0.009 [−0.023, 0.006] 0.230
*The reference groups are: females for sex; blacks for race; non-exposed for his-
tory of exposure to illness and breast-feeding for type of feeding during 6 months
following birth.
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4.3.2.3 CD8+ T cells
Figure 4.3 shows a comparison of independently predicted counts of CD8+ T for each of
the investigated covariate.
1. Sex: There was no observable difference for male and female subjects.
2. History of exposure to illness: Those subjects who had a history of maternal ex-
posure to illness had higher cell count predictions at birth compared to those who
had no history of exposure to illness. At older ages, the two fits were not substan-
tially different.
3. Race: Black children show higher predicted cell counts at birth, compared to
Mixed race/Coloureds for the first 2.5 years after which predicted cell counts re-
main approximately the same for both groups.
4. Type of food: There was little difference between the food types. However, bottle-
fed children had slightly increased cell counts at birth compared to those on breast-
milk or mixed meals.
Stellenbosch University  https://scholar.sun.ac.za
55 4.3. Results
A
b
so
lu
te
 c
o
u
n
ts
 (
ce
ll
s/
µ
L)
Age (months)
Figure 4.3: A plot showing age-related changes in CD8+ across different covariates.
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Table 4.4: Parameter estimates for the extended model for CD8+.
Estimate 95% Confidence Interval p-value
β1 1467.138 [1006.002, 1928.274] 0.000
β3 0.232 [0.009, 0.455] 0.041
β0
β0.(Intercept) 612.498 [344.004, 880.992] 0.000
γ0.(Sex - Male) 105.622 [−46.678, 257.923] 0.173
α0.(Race - Coloured) 49.498 [−176.563, 275.558] 0.667
τ0.(Exposure - Exposed) 50.235 [−100.307, 200.778] 0.512
φ0.(Feeding - Bottle) -64.146 [−357.480, 229.188] 0.667
φ0.(Feeding - Mixed) -295.367 [−578.467,−12.268] 0.041
β2
β2.(Intercept) 0.039 [0.017, 0.061] 0.001
γ2.(Sex - Male) 0.004 [−0.008, 0.015] 0.529
α2.(Race - Coloured) 0.004 [−0.009, 0.017] 0.581
τ2.(Exposure - Exposed) 0.001 [−0.011, 0.012] 0.912
φ2.(Feeding - Bottle) -0.011 [−0.039, 0.017] 0.430
φ2.(Feeding - Mixed) -0.025 [−0.045,−0.006] 0.011
*The reference groups are: females for sex; blacks for race; non-exposed for history
of exposure to illness and breast-feeding for type of feed during 6 months.
A statistically significant difference was observed in adjustment parameters for feeding
type. Children on mixed meals had low CD8+ cells at birth compared to those on bottle
or breast-milk (p = 0.041). The rate of cell decline was also slower in children on mixed
meals (p = 0.011) compared to the others. However, Age-related changes in CD8+ cells
was not statistically different for breast-fed versus bottle-fed children. There was no
statistical differences in sex, race and exposure to illness for CD8+ T cells.
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4.3.2.4 CD19+ B cells
Figure 4.4 shows a comparison of independently predicted counts of CD19+ B cells for
each of the investigated covariate.
1. Sex: The predicted counts for male and female subjects did not significantly differ.
2. History of exposure to illness: Subjects without a history of maternal exposure to
illness had slightly higher counts at birth but at older ages those who were exposed
to illness had slightly higher counts.
3. Race: Black children had slightly higher predicted counts compared to Mixed
race/Coloureds in the first year of life, after which the trend was similar in the
two groups.
4. Type of food: Bottle-fed children had higher predictions at birth compared to the
other two groups. Breast-fed children had slightly higher counts at birth compared
to those on mixed meals in early life. At older ages predictions were similar for
the three groups.
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Figure 4.4: A plot showing age-related changes in CD19+ across different covariates.
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Table 4.5: Parameter estimates for the extended model for CD19+ B lymphocytes.
Estimate 95% Confidence Interval p-value
β1 1832.428 [1301.979, 2362.877] 0.000
β3 0.198 [−0.010, 0.406] 0.061
β0
β0.(Intercept) 359.313 [190.086, 528.540] 0.000
γ0.(Sex - Male) 16.675 [−72.716, 106.066] 0.714
α0.(Race - Coloured) -93.485 [−240.543, 53.572] 0.212
τ0.(Exposure - Exposed) 114.128 [22.949, 205.306] 0.014
φ0.(Feeding - Bottle) -151.953 [−296.598,−7.309] 0.040
φ0.(Feeding - Mixed) -94.961 [−200.481, 10.559] 0.078
β2
β2.(Intercept) 0.044 [0.025, 0.063] 0.000
γ2.(Sex - Male) 0.003 [−0.006, 0.011] 0.516
α2.(Race - Coloured) -0.008 [−0.024, 0.007] 0.285
τ2.(Exposure - Exposed) 0.014 [0.003, 0.025] 0.010
φ2.(Feeding - Bottle) -0.015 [−0.026,−0.004] 0.011
φ2.(Feeding - Mixed) -0.012 [−0.022,−0.001] 0.027
*The reference groups are: females for sex; blacks for race; non-exposed for his-
tory of exposure to illness and breast-feeding for type of feeding during 6 months
following birth.
Type of feeding and history of exposure to illness parameter estimates were statistically
significantly different for CD19+. Bottle-fed children had lower CD19+ at birth (p=0.040)
compared to those on mixed meals or breast-milk. There was no significant difference at
birth between those on mixed meals and breast-milk. Cell decline was lower in children
on bottle meals (p=0.011) and mixed meals (p=0.027) compared to those fed on breast-
milk. Children who had a history of prior exposure to illness had higher counts at birth
(p=0.014) compared to those who had no history of exposure. The rate of cell decline was
faster for exposed children (p=0.010) compared to those without a history of exposure.
Sex and race had no apparent influence on the parameters.
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4.3.2.5 Ratio of CD4+ naive/memory T cells
Figure 4.5 compares independently predicted counts of ratio of CD4+ naive/memory T
cells for the investigated covariates.
1. Sex: Predicted counts for females were slightly higher than those for males at birth
but slightly lower at older ages. Both males and females had a double exponential
trend.
2. History of exposure to illness: Subjects who had no history of exposure to illness
had slightly lower predicted cell counts compared to those with previous exposure
in the first 6 months from birth, but this rapidly increased above the previously
exposed group. At older ages, the predicted counts for the previously exposed
subjects were higher.
3. Race: Black children had higher predicted counts compared to Mixed race/Coloureds
in the first year of life, after which their predicted cell counts descended to lower
values than those of the mixed race children.
4. Type of food: Children fed on mixed meals and breast-milk had similar trend of
predicted counts. Bottle-fed children had lower predicted counts than those of the
above two feeding groups at all ages.
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Figure 4.5: plot showing age-related changes in Ratio CD4+ naive/memory T cells
across the different covariates.
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Table 4.6: Parameter estimates for the extended model for Age-related changes in the
ratio of CD4+ naive/memory T cells.
Estimate 95% Confidence Interval p-value
β1 3.951 [3.131, 4.771] 0.000
β3 0.287 [0.081, 0.494] 0.006
β0
β0.(Intercept) 1.240 [0.747, 1.732] 0.000
γ0.(Sex - Male) 0.028 [−0.270, 0.326] 0.852
α0.(Race - Coloured) -0.047 [−0.432, 0.339] 0.811
τ0.(Exposure - Exposed) 0.013 [−0.264, 0.291] 0.924
φ0.(Feeding - Bottle) -1.413 [−2.006,−0.820] 0.000
φ0.(Feeding - Mixed) 0.385 [−0.012, 0.782] 0.057
β2
β2.(Intercept) 0.044 [0.025, 0.064] 0.000
γ2.(Sex - Male) 0.011 [0.001, 0.021] 0.046
α2.(Race - Coloured) -0.006 [−0.019, 0.006] 0.302
τ2.(Exposure - Exposed) 0.003 [−0.004, 0.010] 0.362
φ2.(Feeding - Bottle) -0.029 [−0.044,−0.013] 0.000
φ2.(Feeding - Mixed) 0.029 [−0.006, 0.064] 0.102
*The reference groups are: females for sex; blacks for race; non-exposed for history
of exposure to illness and breast-feeding for type of feed during 6 months.
The dynamics in the ratio of CD4+ naive/memory T cells was not statistically different
in terms race (p=0.811) and history of prior exposure to illness (p=0.924). Bottle-fed
children had lower cell counts at birth (p=0.000) and a lower rate of cell decline with
advancing age (p=0.000) as compared to the other groups. Breast-fed and mixed meal
fed children were not statistically different. Although the number of cell counts at birth
for female children was not statistically different from that of males (p=0.852), the rate
of cell decline with advancing age was lower in females compared to males (p=0.046).
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4.3.2.6 CD16+CD56+ T cells
Figure 4.6 compares independently predicted counts of ratio of CD16+CD56+ for each
of the investigated covariates.
1. Sex: At birth, female children had slightly higher predicted cell counts than males.
Thereafter, females and males had similar trends. Male children had a double
exponential trend while females had a general exponential decline after birth.
2. History of exposure to illness: Children who had a history of exposure to ma-
ternal illness had slightly higher counts than those who were without a history of
exposure to illness at all ages.
3. Race: Mixed race/Coloured children had higher predicted cell counts than blacks
in early life. However, predicted cell counts for black children rise from birth
to 1 year, followed by an exponential decline, while mixed race children decline
exponentially from birth.
4. Type of food: There was no observable difference in the trend of predicted count
for children fed on bottle versus mixed food. Predicted cell counts were higher for
breast-fed children versus those on bottle and mixed feeds at all ages.
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Figure 4.6: A plot showing age-related changes in CD16+CD56+ across the covariates.
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Table 4.7: Parameter estimates for the extended model for Age-related changes in
CD16+CD56+ T cells.
Estimate 95% Confidence Interval p-value
β1 546.951 [307.274, 786.628] 0.000
β3 1.561 [−1.861, 4.983] 0.370
β0
β0.(Intercept) 374.918 [273.012, 476.824] 0.000
γ0.(Sex - Male) -48.268 [−121.463, 24.926] 0.196
α0.(Race - Coloured) -132.074 [−230.296,−33.852] 0.009
τ0.(Exposure - Exposed) 79.296 [3.949, 154.644] 0.039
φ0.(Feeding - Bottle) 29.459 [−90.077, 148.995] 0.628
φ0.(Feeding - Mixed) 136.156 [51.010, 221.302] 0.002
β2
β2.(Intercept) 0.202 [−0.037, 0.440] 0.097
τ2.(Sex - Male) -0.021 [−0.056, 0.014] 0.237
φ2.(Race - Coloured) -0.155 [−0.386, 0.076] 0.187
φ2.(Exposure - Exposed) 0.030 [−0.019, 0.079] 0.231
γ2.(Feeding - Bottle) 0.012 [−0.045, 0.069] 0.671
α2.(Feeding - Mixed) 1.128 [−1.500, 3.757] 0.399
*The reference groups are: females for sex; blacks for race; non-exposed for history
of exposure to illness and breast-feeding for type of feed during 6 months.
Females and males were not statistically different (p = 0.196). Children on mixed meals
had higher cell counts at birth (p=0.002) compared to the breast-fed and bottle-fed,
which were not statistically different. Significant differences in cell counts at birth were
visible in race and exposure to illness. Mixed race/coloured children had low cell counts
at birth (p = 0.009) compared to black children. Children who were exposed to mater-
nal illness had higher cell counts at birth (p = 0.039) compared to those not exposed.
However, no statistically significant differences were visible in the rate of decline in cell
counts with advancing age, with regard to race and history of exposure to illness.
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4.3.2.7 CD3−CD56+ T cells
Figure 4.6 compares the ratio of CD3-CD56+ T cells for the investigated covariates.
1. Sex: Predicted cell counts for females and males were not different after the first
year from birth. Within the first year from birth, females had higher predicted
cell counts than males. In addition, the predicted cell count for females exhibits
a general exponential decline trend immediately from birth, while that of males
shows a double exponential trend.
2. History of exposure to illness: There is no observable differences in the trend
of predicted cell counts for children who had an history of exposure to maternal
illness and those who had no history of exposure to illness both at birth and older
ages.
3. Race: Coloured children had higher predicted cell counts than black ones at early
stages of life. However, predicted cell counts for black children seem to rise from
birth up to about 1 year, followed by an exponential decline to older ages while
that of coloured children starts to decline exponentially from birth.
4. Type of food: There is no observable differences in the trend of predicted cell
counts for the children fed on bottle and mixed feeds. However, at birth and older
ages, the predicted cell counts are higher for children fed on breast milk than those
fed on either bottle and mixed feeds.
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Figure 4.7: A plot showing age-related changes in CD3−CD56+ across the covariates.
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Table 4.8: Parameter estimates for the extended model for Age-related changes in
CD3−CD56+ T cells.
Estimate 95% Confidence Interval p-value
β1 1073.496 [821.155, 1325.837] 0.000
β3 0.009 [−0.013, 0.030] 0.439
β0
β0.(Intercept) 446.406 [105.253, 787.559] 0.010
γ0.(Sex-Male) -31.054 [−136.882, 74.775] 0.564
α0.(Race-Coloured) -95.874 [−290.628, 98.881] 0.334
τ0.(Exposure-Exposed) 61.881 [−54.097, 177.858] 0.295
φ0.(Feeding-Bottle) 55.999 [−165.194, 277.192] 0.619
φ0.(Feeding-Mixed) -402.551 [−776.150,−28.952] 0.035
β2
β2.(Intercept) 0.045 [0.023, 0.068] 0.000
γ2.(Sex-Male) -0.001 [−0.006, 0.004] 0.731
α2.(Race-Coloured) -0.005 [−0.019, 0.010] 0.509
τ2.(Exposure-Exposed) 0.001 [−0.005, 0.008] 0.683
φ2.(Feeding-Bottle) 0.013 [−0.038, 0.064] 0.610
φ2.(Feeding-Mixed) -0.030 [−0.054,−0.007] 0.012
*The reference groups are: females for sex; blacks for race; non-exposed for his-
tory of exposure to illness and breast-feeding for type of feed during 6 months.
CD3-CD56+ T cells dynamics were not statistically different with regard to sex, race and
history of exposure to illness. Children fed on mixed meal had lower counts (p = 0.035)
and lower rates of cell decline (p = 0.012) with advancing age compared to those fed on
the other two types of food.
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4.4 Summary
4.4.0.1 Influence of sex
Separate empirical fits for males and females demonstrated measurable differences in
CD3+, CD4+, ratio of CD4+ naive/memory, CD16+CD56+, CD3-CD56+ T cells. There
have been similar findings in prior studies [20, 39, 92]. However, in the extended anal-
ysis, statistically significant sex differences were only observed in the ratio of CD4+
naive/memory T cells. A study by Rudy et al. [92] observed sex differences in CD4+
and CD3-CD56+ T cells.
4.4.0.2 Influence of race
Our extended covariate regression analysis did not demonstrate any statistically signif-
icant racial differences for the majority of the investigated lymphocytes subsets, CD3+,
CD4+, CD8+, CD19+, ratio of CD4+ naive/memory, and CD3-CD56+ T cells. Similar
findings have been found in other regions [37, 92, 97, 107]. Our study only demon-
strated statistically significant racial differences in CD16+CD56+ T cells. Other studies
have shown evidence of ethnic immunological variations, mostly between blacks and
white HIV positive individuals [5, 35, 60].
4.4.0.3 Influence of history of exposure to illness
This study demonstrated an influence of exposure to illness in the CD19+ and CD16+CD56+
lymphocyte subsets. A prior study on HIV-positive gay men showed similar influences
on cell counts and proliferative responses in CD4+, CD8+ and CD56+ [55].
4.4.0.4 Food in the first 6 months following birth
Our results on separate empirical fits for the breast-fed, bottle-fed and mixed meal-fed
consistently indicated differences in age-related changes for lymphocyte subsets. Fur-
ther, our extended regression also demonstrated differences for CD8+, CD19+, ratio of
CD4+ naive/memory, CD16+CD56+ and CD3-CD56+ T cells. Prior studies have re-
ported similar results [6, 62].
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Biomarker Reference Range
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5.1 Introduction
Prior studies of age-related reference ranges in industrialized countries have variously
proposed the use of centile curves, or growth-charts, obtained by applying Box-Cox
transformations to reference data [22, 23], or by empirically grouping particular age
ranges into non-continuous ‘age-blocks’ [24, 26, 50, 67, 69, 71, 93, 105]. However, studies
of thymic maturation have shown that immunological biomarkers change continuously
from birth towards adulthood [7, 29, 50]. For this reason, ‘age-block’ methods have
the disadvantage of a loss of precision in indicating whether patients that lie close to
the limits of particular ranges are normal or not. Ideally, age-related changes should
be described as a continuous process. Furthermore, although centile curves are con-
tinuous they provide no opportunity for mechanistic biological inferences regarding ob-
served changes over time. In the present study we review prior methods for calcu-
lating age-related reference ranges (see Section 2.3) and then present a model-based,
age-continuous statistical method without the above disadvantages.
70
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5.2 Methods
Normal reference ranges are those sets of values falling within the inner 95% for a lab-
oratory test measured on healthy subjects of a population. Using a Gaussian normality
assumption, references ranges are values measured in the ‘healthy’ group with 2 stan-
dard deviations on either side of the mean. This accounts for 95% of the population.
Figure 5.1: An illustration of how deviation from the mean accounts for different per-
centages of the sample. For the normal distribution, the values less than one standard
deviation away from the mean account for 68.27% of the set; while two standard de-
viations from the mean account for 95.45%; and three standard deviations account for
99.73%. The values within two standard deviations are the normal reference range.
Definition 5.2.1. Model-based Reference Range
An α% reference range is the set of values of an observed variable Y, comprising α% of the data
distributed about a given measure of central tendency, either the mean or median function/s of
the data in terms of a probability scale. An α% model based reference range can, therefore, be
defined as the set of values bounded by upper and lower fitted curves corresponding to the upper
and lower data limits for the observed Y.
Assumptions:
1. Reference ranges are a particular Zα-shift of the standard deviations of residuals,
on a continuous time scale, away from the fitted central function. A Zα is the Z-
score corresponding to α% significance level. This level is adjustable to any desired
value.
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2. The positive and negative, Zα-shifted residuals are considered independent and
are modelled separately.
3. Since the continuous reference ranges curves are fitted independently on either
side of the central fitted function, each intrinsically incorporates the distributional
characteristics of the data above or below the fit of the central model-function.
4. Both upper and lower Zα-shifted curves are modelled with their own parameter
values, rather than by the parameters of the data as a whole.
5. Although the fitted Zα-shifted curves are independent, they employ the same class
of function as the central curve, with the same number of parameters, although
these differ numerically. For example, if the central function is considered a 4-
parameter double exponential, then so too is the particular Zα shifted curve, above
or below it.
Proposition 5.2.2. The upper and lower data thresholds at, for example, a 95% reference range
of a random variable Y(t), are denoted by U(t) and L(t) respectively. Let f (t, β) be the fitted
values of Y(t) and z the Z-score corresponding to α%, then
U(t) = f (t, β) + z(sd+(t)) (5.2.1)
(5.2.2)
and
L(t) = f (t, β)− z(sd−(t)), (5.2.3)
(5.2.4)
where t is the age in months, sd+(t) and sd−(t) are vectors, or ‘running’ standard deviation for
the n samples of positive and negative residuals respectively.
Let ψ denote the probability that X lies within the interval [U ,L], then
Pr(L < X < U ) = ψ
Pr
(L− µ
σ
<
X− µ
σ
<
U − µ
σ
)
= ψ. (5.2.5)
For a normally distributed X, the Z-score is given by Z = X−µσ , thus equation (5.2.5)
becomes
Pr
(L− µ
σ
< Z <
U − µ
σ
)
= ψ.
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Thus
L− µ
σ
= −z and U − µ
σ
= z
or
U = µ+ zσ (5.2.6)
and
L = µ− zσ. (5.2.7)
Which illustrates 5.2.1 and 5.2.3.
The main idea is that U(t) and L(t) are two datasets that can be modelled independently
to obtain the parameter estimates for the upper and lower fitted values. The model-
based reference ranges are then the sets of values falling within the upper and lower
fitted values.
The calculation of U(t) and L(t) in 5.2.1 and 5.2.1, respectively, involves a ‘running’
partitioning of residuals with an arbitrary size k, where k refers to nearest neighbours.
Any value of k is possible, but we empirically determined that values of 4 or 5 were
optimal.
Suppose we have r1, r2, · · · , rn residuals defined as
ri(t) = yi(t)− f (ti, β), i = 1, 2, 3, · · · , n,
where yi(t) are the observed values and f (ti, β) are the fitted values. Positive residuals
are r+i (t) if ri(t) > 0 while the negative residuals are r
−
i (t) if ri(t) < 0. The k-nearest
neighbours ’running’ standard deviations of the positive and negative residuals are de-
fined as in 5.2.8 and 5.2.9, respectively,
sd+(t) =

√√√√1
k
k
∑
i=1
(r+i (t))
2,
√√√√1
k
k+1
∑
i=2
(r+i (t))
2,
√√√√1
k
k+2
∑
i=3
(r+i (t))
2, · · · ,
√
1
k
n
∑
i=n−k
(r+i (t))
2

(5.2.8)
and
sd−(t) =

√√√√1
k
k
∑
i=1
(r−i (t))2,
√√√√1
k
k+1
∑
i=2
(r−i (t))2,
√√√√1
k
k+2
∑
i=3
(r−i (t))2, · · · ,
√
1
k
n
∑
i=n−k
(r−i (t))2
 .
(5.2.9)
At 95% reference ranges Zα=95% ' 2 and thus Equations 5.2.1 and 5.2.1 becomes
U(t) = f (t, β) + 2(sd+(t)) (5.2.10)
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and
L(t) = f (t, β)− 2(sd−(t)), (5.2.11)
The terms 2(sd+) and 2(sd−) are the Zα-shifts of the standard deviation of residuals,
away from the fitted values, f (t, β). The positive and negative residuals are not sym-
metrical about the fitted central function. U(t) and L(t) datasets are modelled indepen-
dently to obtain the best fits at the two reference range limits and implicitly automat-
ically adjusts for skewness, kurtosis and any other distributional characteristics in the
population as a whole.
Summary of procedure:
1. Sort the data by ascending age, i.e. from younger to older.
2. Choose the value of k. The choice of an optimal value for k is user defined and
ideally requires an initial inspection of the data. We found that for small samples
(n ≤ 100) the central value along with its 3 or 4 nearest neighbours (k = 4 or k = 5)
and for larger samples, 4 < k ≤ 10. Ideally, the ‘window’ (the value of k) should
be as small as possible.
3. Calculate the fitted values, f (ti, β), of the central regression (function) model.
4. Calculate the residuals, ri(t) = yi(t)− f (ti, β).
5. Determine positive residuals, denoted by r+i (t), if ri(t) > 0 and negative residuals,
denoted by r−i (t) , if ri(t) < 0.
6. Independently, calculate the k-nearest neighbours ‘running’ standard deviations,
sd+(t) and sd−(t).
7. Calculate the Z-score corresponding to the desired α% reference ranges.
8. Calculate U(t) and L(t) datasets using Equations 5.2.10 and 5.2.11.
9. Fit the appropriate model to the result in (8). This generates both the parameter
values at the respective upper or lower data thresholds and gives the desired age-
related reference ranges.
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Parameter estimates 
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𝑍𝛼 
Figure 5.2: Flowchart of the model-based estimation procedure.
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In the present case, we fit the double exponential model (equation 3.3.2) on the seven
lymphocyte subsets and parameter values obtained using the weighted generalized
nonlinear least squares estimation method as is available in package nlme in the R statis-
tical environment. Thereafter, the model is re-used to estimate the new set of parameters
for U(t) and L(t), thus providing the model-fits at the upper and lower 95% thresholds
respectively. We also compare our results to those obtained in centile curves for some of
the lymphocyte cell markers.
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5.3 Results
Table 5.1 summarizes the parameter estimates and significance for the central (mean),
lower and upper fits for a 95% model-based reference ranges. An age-continuous refer-
ence ranges prediction can be obtained by inputting the parameter estimates back into
the model. The statistical significance level for the parameters is set at p < 0.05.
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Table 5.1: Parameter estimates for the central (mean), lower and upper fits for a 95%
model-based reference ranges.
C
en
tr
al
Es
ti
m
at
es
Lo
w
er
Es
ti
m
at
es
U
pp
er
Es
ti
m
at
es
C
el
lM
ar
ke
rs
Pa
ra
m
et
er
s
Es
ti
m
at
e
95
%
C
I
p-
va
lu
e
Es
ti
m
at
e
95
%
C
I
p-
va
lu
e
Es
ti
m
at
e
95
%
C
I
p-
va
lu
e
β
0
18
38
.1
14
[1
67
4.
60
3,
20
01
.6
25
]
0.
00
0
11
54
.2
36
[1
08
4.
80
4,
12
23
.6
68
]
0.
00
0
26
60
.3
91
[2
60
7.
06
0,
27
13
.7
23
]
0.
00
0
C
D
3+
β
1
63
90
.3
89
[5
24
0.
05
5,
75
40
.7
23
]
0.
00
0
34
13
.5
60
[3
00
2.
21
0,
38
24
.9
10
]
0.
00
0
10
26
6.
21
9
[9
29
5.
17
6,
11
23
7.
26
2]
0.
00
0
β
2
0.
04
7
[0
.0
40
,0
.0
55
]
0.
00
0
0.
04
1
[0
.0
36
,0
.0
45
]
0.
00
0
0.
05
6
[0
.0
53
,0
.0
59
]
0.
00
0
β
3
0.
10
8
[0
.0
45
,0
.1
71
]
0.
00
1
0.
10
7
[0
.0
68
,0
.1
47
]
0.
00
0
0.
12
6
[0
.0
90
,0
.1
62
]
0.
00
0
β
0
11
27
.6
95
[1
00
8.
35
8,
12
47
.0
32
]
0.
00
0
72
6.
01
1
[6
86
.8
27
,7
65
.1
95
]
0.
00
0
16
02
.4
27
[1
54
7.
10
3,
16
57
.7
51
]
0.
00
0
C
D
4+
β
1
49
88
.4
50
[4
26
0.
47
4,
57
16
.4
26
]
0.
00
0
24
46
.8
55
[2
13
5.
88
6,
27
57
.8
25
]
0.
00
0
82
10
.4
55
[7
75
2.
77
1,
86
68
.1
40
]
0.
00
0
β
2
0.
05
0
[0
.0
35
,0
.0
64
]
0.
00
0
0.
05
0
[0
.0
43
,0
.0
57
]
0.
00
0
0.
04
6
[0
.0
31
,0
.0
60
]
0.
00
0
β
3
0.
06
1
[0
.0
06
,0
.1
16
]
0.
03
0
0.
08
4
[0
.0
45
,0
.1
24
]
0.
00
0
0.
03
8
[0
.0
01
,0
.0
75
]
0.
04
5
β
0
72
8.
81
0
[6
43
.1
07
,8
14
.5
12
]
0.
00
0
34
7.
66
4
[3
01
.9
96
,3
93
.3
31
]
0.
00
0
98
9.
08
3
[9
49
.8
76
,1
02
8.
29
0]
0.
00
0
C
D
8+
β
1
13
84
.0
83
[8
09
.4
43
,1
95
8.
72
3]
0.
00
0
61
5.
48
4
[4
90
.7
08
,7
40
.2
59
]
0.
00
0
30
71
.1
53
[2
62
7.
00
6,
35
15
.3
01
]
0.
00
0
β
2
0.
03
8
[0
.0
23
,0
.0
54
]
0.
00
0
0.
02
6
[0
.0
19
,0
.0
33
]
0.
00
0
0.
04
3
[0
.0
38
,0
.0
48
]
0.
00
0
β
3
0.
22
3
[−
0.
01
9,
0.
46
4]
0.
07
1
0.
15
6
[0
.0
76
,0
.2
36
]
0.
00
0
0.
22
6
[0
.1
27
,0
.3
26
]
0.
00
0
β
0
30
8.
14
2
[2
59
.3
98
,3
56
.8
85
]
0.
00
0
18
2.
28
9
[1
65
.1
83
,1
99
.3
95
]
0.
00
0
49
3.
47
5
[4
69
.9
59
,5
16
.9
92
]
0.
00
0
C
D
19
+
β
1
17
76
.4
13
[1
20
1.
93
9,
23
50
.8
88
]
0.
00
0
66
8.
42
7
[5
31
.8
66
,8
04
.9
89
]
0.
00
0
34
96
.1
54
[2
94
4.
95
2,
40
47
.3
56
]
0.
00
0
β
2
0.
03
8
[0
.0
28
,0
.0
48
]
0.
00
0
0.
03
3
[0
.0
27
,0
.0
40
]
0.
00
0
0.
04
3
[0
.0
39
,0
.0
48
]
0.
00
0
β
3
0.
20
7
[−
0.
02
9,
0.
44
2]
0.
08
5
0.
21
8
[0
.0
70
,0
.3
66
]
0.
00
4
0.
19
6
[0
.0
84
,0
.3
09
]
0.
00
1
β
0
1.
02
5
[0
.7
37
,1
.3
14
]
0.
00
0
0.
22
0
[0
.0
17
,0
.4
23
]
0.
03
4
1.
25
0
[1
.0
01
,1
.4
98
]
0.
00
0
R
at
io
C
D
4+
na
iv
e/
m
em
or
y
β
1
2.
78
8
[2
.3
32
,3
.2
44
]
0.
00
0
1.
64
0
[1
.4
62
,1
.8
18
]
0.
00
0
4.
63
6
[4
.3
69
,4
.9
03
]
0.
00
0
β
2
0.
02
6
[0
.0
15
,0
.0
37
]
0.
00
0
0.
01
7
[0
.0
11
,0
.0
24
]
0.
00
0
0.
01
9
[0
.0
16
,0
.0
23
]
0.
00
0
β
3
0.
87
4
[0
.2
00
,1
.5
49
]
0.
01
1
0.
46
2
[0
.2
08
,0
.7
15
]
0.
00
0
2.
60
4
[−
0.
03
1,
5.
23
9]
0.
05
3
β
0
26
5.
37
1
[2
17
.8
48
,3
12
.8
94
]
0.
00
0
10
0.
00
0
[8
2.
42
8,
11
7.
57
2]
0.
00
0
50
0.
92
1
[4
66
.6
86
,5
35
.1
57
]
0.
00
0
C
D
16
+
C
D
56
+
β
1
10
12
.2
23
65
1.
04
5,
13
73
.4
02
0.
00
0
10
0.
00
0
[5
0.
93
4,
14
9.
06
6]
0.
00
0
24
90
.8
47
[2
14
6.
92
2,
28
34
.7
72
]
0.
00
0
β
2
0.
05
7
[0
.0
23
,0
.0
92
]
0.
00
1
0.
04
4
[−
0.
00
1,
0.
08
9]
0.
05
4
0.
07
0
[0
.0
59
,0
.0
81
]
0.
00
0
β
3
0.
07
4
[−
0.
06
5,
0.
21
3]
0.
29
5
0.
10
0
[−
0.
02
6,
0.
22
6]
0.
12
1
0.
10
2
[0
.0
38
,0
.1
65
]
0.
00
2
β
0
33
5.
20
0
[−
19
48
.8
68
,2
61
9.
26
8]
0.
77
3
10
6.
69
6
[7
7.
01
5,
13
6.
37
6]
0.
00
0
49
0.
55
3
[4
57
.2
29
,5
23
.8
78
]
0.
00
0
C
D
3−
C
D
56
+
β
1
10
31
.1
78
[−
10
55
.1
07
,3
11
7.
46
2]
0.
33
2
11
2.
49
5
[5
9.
81
7,
16
5.
17
4]
0.
00
0
25
18
.3
08
[2
15
7.
41
8,
28
79
.1
98
]
0.
00
0
β
2
0.
03
6
[−
0.
01
2,
0.
08
4]
0.
13
8
0.
03
3
[−
0.
02
1,
0.
08
6]
0.
22
9
0.
07
1
[0
.0
60
,0
.0
83
]
0.
00
0
β
3
0.
01
0
[−
0.
23
0,
0.
25
0]
0.
93
6
0.
05
8
[−
0.
03
3,
0.
14
9]
0.
21
2
0.
09
9
[0
.0
32
,0
.1
66
]
0.
00
4
Stellenbosch University  https://scholar.sun.ac.za
79 5.3. Results
Figures 5.3 and 5.4 show the age-continuous fits for model-based 95% reference ranges.
Each plot is comprised of central, lower and upper fitted curves. The age-continuous
reference ranges are the points falling within the two red lines. In all the cell markers
described below, the lower and upper limits of the reference ranges have the same mech-
anistic properties assumed by the central fit, as also described in the model formulation.
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Figure 5.3: Plots showing model-based, age-continuous reference ranges for absolute
counts of CD3+, CD4+, CD8+ and CD19+.
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Figure 5.4: Plots showing model-based, age-continuous reference ranges for absolute
counts of CD16+CD56+, CD3−CD56+ and ratio of CD4+ naive to memory T cells
for healthy South African children aged 12.5 years and below. The fits assume similar
mechanistic properties of the described model.
Figure 5.5 compares the fits obtained using centile curves with the model-based ap-
proach. The two methods provide somewhat similar central predictions, with the ex-
ception of the double exponential pattern that is noticeable at earlier ages using the
model-based method. The methods predict a similar exponential decline at later ages.
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Overall, centile curves give wider reference ranges compared to the model-based ap-
proach, i.e. given that the chosen Zα-shift from the central function was chosen as the
95% range the latter method is less sensitive to residual ‘noise’ than the former. This was
found to be uniformly true for all the biomarkers the method was applied to.
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Figure 5.5: A comparison between centile curves (black lines) and model-based fits
for absolute counts of CD3+, CD4+, CD8+ and CD19+. At early ages, centile curves
(black lines) estimate wider, and simpler single-exponential-like, reference ranges than
the double exponential model (red lines).
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5.4 Summary
In this chapter we presented an alternative method for estimating age-related reference
ranges based on semi-mechanistic models. Not all lymphocyte cell-markers follow a sim-
ple exponential decline over time, and a reference range estimation method which in-
corporate alternate models is consequently necessary. The model-based method allows
for parameter estimation at the 95% limits which may be compared with other reference
populations. Reference range estimation is also possible over age-continuous intervals.
Centile curves remain appropriate in cases where the family of the underlying distribu-
tion of the smoothing spline is known. However, in the above examples this approach
predicted only a simple exponential decline with age and gave generally wider reference
ranges at early ages. This was the same as that proposed by a prior European study [48].
The reference ranges of our model-based method follows the same trend as that of the
fitted central function, which is in agreement with prior empirical investigations and
studies [7, 8, 24, 50, 71, 95, 111].
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Discussion and Conclusion
In this thesis we have reviewed the biological background of the study, mathematically
described age-related changes in immunological biomarkers and described a method
to construct age-continuous model-based reference ranges for healthy South African
children. We compared the quality of fits for double and single exponential models,
extended the double exponential model to incorporate the covariates and later described
and implemented a model-based method for estimating reference ranges.
6.1 Discussion
In Chapter 3, our analysis demonstrated age-related changes in lymphocyte cell markers
and established that the double exponential model was the best candidate model for de-
scribing such changes. As indicated above the paediatric levels are indeed higher than
in adults. This have been attributed to the lack of functional maturity of the immune
system, leading to it undergoing sequential development stimulated by both genetic
factors and induced activation following exposure to new antigens [51]. The prolifer-
ation and maturation processes continue until adequate levels of immune surveillance
have been reached [24]. Findings in highly ‘immune-exposed’ resource limited African
settings have demonstrated that the levels of some markers may decrease in an expo-
nential manner from a maximum at birth, [50, 69], in the same way as that proposed
by a prior European study [48]. However, empirical measurements from our own data
demonstrate that the counts of some of the immunophenotypes initially increase in the
first year and then decrease thereafter which is in agreement with several prior studies
[24, 33, 95].
83
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The observed patterns in the SSA data may be due to poor diets with vitamin and iron
deficiencies and exposure to more varied and more pathogenic antigens at younger ages.
Iron deficiency may lead to impaired hematopoiesis, chronic blood loss may occur due
to hookworm infestation and in SSA exposure to tuberculosis is more common. Such
exposures would tend to drive up immunophenotype counts at younger ages. A lim-
itation of the current approach was the assumption of an exponential decline in cell
markers with age in the absence of a purely mechanistic model of the underlying biolog-
ical processes involved. Our models were semi-mechanistic; however, their form agrees
with that proposed in prior mechanistic studies [24, 33, 95].
In Chapter 4 we presented an extension of the double exponential model to investigate
the effect of covariates, ie. sex, race, type of food within the first 6 months following birth
and history of maternal exposure to illness. A large historical study has identified the
need for covariate and region specific investigations of lymphocyte subsets. Each pop-
ulation should ideally have its own reference range, which might be updated as socio-
demographic influences change [20]. The differences between males and females that
we demonstrate might be due to differences in sex hormones [92], genetic and environ-
mental factors and harboring of small numbers of cells that originated in a genetically
different individual (microchimerism); and become more pronounced with the onset of
puberty [13, 39, 40]. We observed very little effect of race in our study. However, the ob-
served racial differences in previous studies might be due to the genetic variations across
the racial groups [5, 35, 60]. We observed that changes in the majority of the cell markers
were associated with the type of food given to the infants in the first 6 months follow-
ing birth. Malnourishment may compromise immune system development. Breast milk
provides passive immunotherapy through maternal immunoglobulin, and consequent
gene expression, all of which prevents common infant infections [62, 106, 117]. Prior
studies have demonstrated that bioactive factors in breast milk catalyze the differenti-
ation and growth of B lymphocytes and initiate the production of particular antibodies
[6, 62]. Our study did demonstrate that exposure to maternal illness influenced some of
the lymphocyte cell markers investigated. However, the effect of exposure to such risk
factors remains unclear [1, 26, 27, 61]. The interpretation of such findings is also compli-
cated by the fact that the paediatric subjects in this study were specifically selected only
if they were judged to be healthy.
In Chapter 5 we presented the implementation procedure and results of age-continuous,
model-based reference ranges estimation method. Prior empirical studies have used dif-
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fering age-block ranges [24, 95], which adds to the difficulty of comparing results across
cohorts. The two studies which the South African National Health Laboratories were
using as the de facto reference ranges were conducted in the EU and the US [24, 95]. For
resource-limited, SSA circumstances, this is obviously not ideal, as the the environmen-
tal and immunological milieu of these populations are likely to differ. Prior empirical
studies have also transformed data using, for the most part, logarithmic or Box-Cox
transformations [30, 96, 116]. Back transformation is then required to obtain parame-
ter estimates. Furthermore, centile curves are continuous but use smoothing splines,
which do not allow for mechanistic interpretations of data patterns. Our approach elim-
inates the need for age-blocks, forward or back transformation, enables the estimation
of age continuous reference ranges, and incorporates mechanistic model-based assump-
tions. Such models, when applied to paediatric immunological markers can estimate
the rate of cell death, predict cell population numbers at birth, or at any given age at the
thresholds of the 95% reference range. In addition, this method is relatively flexible and
can be extended to incorporate covariates affecting the distribution of the reference pop-
ulation, e.g. sex, race, maternal smoking, maternal HIV status and child feeding habits.
A potential limitation of our method is the assumption that particular reference ranges
are a Zα-shifted ‘running’ standard deviations of residuals from the central fitted-function.
However, all approaches to reference range estimation employ assumptions of some
sort, including the fact that what is ‘normal’ incorporates a particular percentile range
of the population under study. As the Zα-shift is adjustable in our method, any particu-
lar range can be chosen based on an evaluation of the data in question.
6.2 Conclusion
Using ‘age snap-shot’ cross-sectional data we established that the continuous double ex-
ponential model was the ideal for predicting change in blood lymphocyte cell markers
for the cohort of healthy South African children. This study has methodological value in
both resource-limited and industrialized settings, in that it may lead to the development
of an easy-to-use laboratory tool. This might take the form of a spreadsheet, into which
a technician could enter the patient’s age and particular cell-count and immediately
determine whether the sample is within normal ranges or not. We have proposed an
alternative method for constructing reference ranges, which has the flexibility to incor-
porate prior mechanistic assumptions, is age-continuous, and which also demonstrates
agreement with empirical measurements and prior mechanistic studies. The method has
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been implemented as R code and will be made available as an R software package.
Future studies might involve additional mathematical verification, such as evaluation
of model covariates in data for patients that are unhealthy, i.e. not healthy subjects,
sensitivity analysis for further evaluation of distributional assumptions and additional
comparisons to prior reference range determination methods.
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